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 ABSTRACT  
 
Delta-Notch signaling is crucial for development of nearly every tissue in 
metazoans.  Signals received by the Notch receptor influence transcription of select target 
genes that ultimately restrict the developmental fate of the signal receiving cell with 
respect to its neighbors.  The Notch pathway also functions in contexts of abnormal 
proliferation and differentiation, e.g. cancer and inflammation.  Therefore, understanding 
the regulation of signaling through the Notch receptor protein at the cellular and 
molecular level is of great significance.  In this dissertation, I investigated three ways in 
which Notch signaling is regulated, namely (1) proteolysis of the Delta ligand; (2) 
endocytosis of the Delta ligand; and (3) proteolysis of the Notch receptor.. 
The Delta protein has three functions. First, Delta is a ligand for Notch when 
bound to it from an adjacent cell. Second, Delta is an inhibitor of Notch when co-
expressed with it in the same cell. Third, Delta is hypothesized to be a receptor and, upon 
binding to Notch, signals to nucleus. Delta undergoes proteolysis by ADAM proteases 
and there are two contradictory models for the role of Delta cleavage: (1) cleavage 
disables Delta function; and (2) cleavage activates Delta function.  Overall, the results 
presented in this dissertation strengthen the first model and weaken the second one.  
Consistent with the first model, we showed that preventing Delta cleavage strengthens its 
ligand function.  As well, when co-expressed in the same with Notch, Delta cleavage is 
upregulated therefore disabling Delta function as inhibitor of Notch. In contrast to the 
second model, we showed that Delta proteolysis does not follow a previously established 
pattern of cleavages typical of cell surface proteins that are activated by proteolysis.  
Delta also undergoes endocytosis. Two general models have emerged that are 
again contradictory: (1) endocytosis downregulates cell surface expression of Delta and 
therefore diminishes its ability to bind Notch; (2) endocytosis of Delta invokes activation 
of Notch signaling. Overall, our results strengthen the first model and weaken the second 
one.  In support of the first model, we first demonstrated that Notch activation shows a 
linear relationship to the amount of Delta ligand present on the cell surface and that 
subsequent inhibition of cell surface expression of Delta leads to its loss of function.  In 
contrast to the second model, we showed that endocytosis of Delta is not required to 
activate Notch. We also resolved that earlier evidence in support for this model stemmed 
from misinterpretations of the properties of a Delta mutant protein. 
Proteolysis of Notch activates the signaling cascade.  Binding of Delta to Notch 
was previously regarded as a requisite regulatory step to invoke receptor proteolysis. We 
identified the ability of Kuzbanian and TACE, ADAM proteases that cleave Notch in 
response to Delta stimulation, to activate Notch in a ligand-independent manner. 
Altogether, our results demonstrate that proteolysis and endocytosis of Delta are 
independent mechanisms that act to downregulate Delta function and are therefore an 
important means of attenuating the Notch signal.  Alternatively, we find a novel means of 
enhancing Notch signals in specific contexts, namely through ligand-independent Notch 
activation by the ADAMs Kuzbanian and TACE. With respect to the latter observation, 
Kuzbanian and TACE expression is known to be elevated in several human diseases,  and 
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CHAPTER 1: LITERATURE REVIEW 
1.1: Introduction 
A central question in developmental biology is how a single pluripotent cell 
multiplies and differentiates into a well organized multicellular organism. During early 
metazoan (multicellular animals) development, signaling regulated gene expression relies 
on five fundamental pathways: Notch, Transforming Growth Factor-β (TGF−β), Wnt, 
receptor tyrosine kinases (EGF, FGF, PDGF, etc.), and Hedgehog [1]. Delta-Notch 
signaling is a mechanism of specifying fates among adjacent cells through direct cell-cell 
interaction and is found in many contexts where neighboring cells need to adopt different 
cell fates. Notch signaling was first identified in Drosophila but later was found to be a 
conserved mechanism that is present in many multicellular animals.  Besides regulating 
differentiation during development, Notch signaling is present in adults as well, in niches 
where there is ongoing proliferation and differentiation, for example, in stem cells and in 
cancer. Therefore, the mechanism of Notch signaling has been of great interest, and 
research in the last few decades has revealed a wide variety of ways Notch signaling can 
be regulated. This chapter reviews the relevant core components of the Notch pathway 
and provides background for my dissertation work that addressed several questions of 
Delta and Notch regulation. 
 
1.2: Mechanism of Notch signaling 
Although genetic and molecular studies have identified many genes that interact 
with Notch signaling [2], there are only a few elements that make up the core of the 
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Notch pathway: the Notch receptor and the Delta ligand, ADAM and γ-secretase 
proteases, and the Su(H) transcription factor. Serrate, another Drosophila Notch ligand, 
shows little function in neurogenesis and will not be discussed further. All metazoan 
organisms have one or more orthologs of these proteins [3]. Unless otherwise noted, all 
proteins mentioned in this review are from Drosophila melanogaster, where in general 
there exists only one ortholog of each of the above.  
Notch is a cell surface receptor that receives signals from the cell surface ligand, 
Delta, on adjacent cells (Fig. 1-1). Upon binding to Delta, Notch undergoes a cleavage by 
an ADAM protease in the juxtamembrane domain followed by a γ-secretase cleavage 
inside the transmembrane domain [4,5]. The cytosolic tail of Notch (NICD) is then free to 
translocate to the nucleus where along with the Suppressor of Hairless (Su(H)) [6] it acts as 
a transcriptional co-activator of the genes of the Enhancer of Split locus (E(Spl)) (Fig. 1-1) 
[7]. This locus encodes seven basic helix-loop-helix (bHLH) proteins (Mδ, Mβ, Mγ, M3, 
M5, M7, and M8) that act as transcriptional repressors for a number of genes that regulate 
cell fate decisions [7,8]. An optimal DNA target sequence for all seven E(Spl) proteins is 
the palindromic 12-bp consensus sequence 5’-TGGCACGTG[C/T][C/T]A-3’ [8]. One 
target of these repressors is the Achaete-Scute complex that encodes proteins involved in 
the segregation of neuronal and epidermal cell lineages in the proneural ectoderm [9].  
The DNA consensus sequence for Su(H) binding sites is 5’-YGTGDGAA-3’ [10]. 
In the absence of Notch signaling, Su(H) along with a co-repressor act as a repressor of 
E(Spl) genes. Following Notch activation, NICD displaces this co-repressor and acts as a 
co-activator ([11] and reviewed in [12]). This dual role of Su(H) as an “off” and “on” 
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switch ensures tighter control over transcription of cell fate genes (reviewed in [3]). It 
should be noted that Su(H) is very ubiquitous transcriptional factor and E(Spl) is only one 
of its many targets. Computational studies show that over 5000 genes in Drosophila 
genome have at least one binding site for Su(H) [10]. Since it takes multiple Su(H) 
binding sites to be responsive to Notch signal, the number of Notch responsive genes is 
estimated to be 50, many of which have not yet been characterized [10]. 
 
1.3: History of the Notch pathway  
Genetic experiments in Drosophila melanogaster at the beginning of the 20th 
century revealed that mutations in the notch locus on the X chromosome lead to the 
appearance of notches in the wing margins (Fig. 1-2 and [13,14]). Studies by Poulson in 
1930s, 40s and 50s showed that mutations in this locus also lead to hypertrophy of 
nervous system (Fig. 1-2 and [15]). Later genetic studies identified Delta and Enhancer 
of Split genes that, when mutated, produce a similar neurogenic phenotype, namely, 
hypertrophy of the nervous system at the expense of epidermal tissue. Collectively, these 
genes became known as the neurogenic loci [2,16,17]. Up to date, genetic and molecular 
studies have identified over 140 genes that affect Notch signaling [2]. 
The notch locus was cloned and sequenced in the mid 1980s in the laboratory of 
Artavanis-Tsakonas [18,19] revealing the identity of the Notch protein as a 2703 amino 
acid (300KDa) single pass type I transmembrane protein. Its large extracellular domain 
encodes 36 tandem epidermal growth factor (EGF)-like repeats and 3 cysteine-rich 
Notch/LIN-12 repeats (LNR). The intracellular domain contains 6 tandem ankyrin 
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repeats, 1 glutamate-rich domain (opa), and 1 PEST sequence (Fig. 1-3 and [19,20]). The 
identity of Notch as a receptor was established in the early 90-s by several research 
groups. Deletion mutagenesis analysis of Notch showed that removing the extracellular 
domain results in gain-of-Notch-function phenotype whereas removing the intracellular 
domain results in loss-of-Notch-function phenotype. These experiments indicated that the 
active form of the Notch receptor is its cytosolic domain suggesting that in order to 
signal, Notch needs to be cleaved [21-23]. Similar results were obtained in the 
laboratories of Young [24] and Simpson [25]. Further research on Notch proteolysis 
revealed that it undergoes at least three cleavages. In mammals, extracellular domain 
Notch is constitutively cleaved in the Golgi complex by a furin-like convertase about 70 
amino acids from the transmembrane domain (S1 cleavage site) to produce two 
fragments: extracellular (p200) and transmembrane (p120) [26]. These fragments form a 
non-covalent, calcium-dependent heterodimer that is presented on the cell surface as the 
mature form of the Notch receptor [27,28]. Whereas Furin cleavage of Notch is required 
in mammals, it is not required in Drosophila [29]. The second cleavage, termed S2, is 
made by an ADAM protease in the p120 fragment of Notch 10-12 amino acids from the 
transmembrane domain of Notch (Fig. 1-1). The C-terminal fragment is termed NEXT 
(Notch extracellular truncation). The identity of the ADAM protease is still debated (see 
the section on Notch and ADAMs). The third cleavage, termed S3, is made by the γ-
secretase complex within the transmembrane domain [30]. This C-terminal fragment of 
cleaved Notch is termed NICD (Notch intracellular domain) and NICD is responsible for 
transmitting the signal to the nucleus [31] (Fig. 1-1). By the end of 1990s, most 
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researchers converged on the current model of Notch activation named the regulated 
intramembrane proteolysis (RIP). According to the RIP model, the rate limiting and 
ligand-regulated cleavage is performed by an ADAM protease followed by a constitutive 
γ-secretase cleavage [32]. It should be stressed that although the rate limiting step in RIP 
is the activity of ADAMs, the cleavage by γ-secretase is a required step in generating the 
functional signal [5]. Mutations in Presenilin (a functional protease in the γ-secretase 
complex) lead to abnormal Notch signaling as well as a variety of other defects [33,34]. 
The delta gene was cloned and sequenced in the late 1980s in the laboratories of 
Campos-Ortega and Muskavitch. Delta is an 880 amino acid single pass transmembrane 
protein. Its extracellular domain contains a Delta-Serrate-ligand (DSL) domain and 9 
EGF-like repeats (Fig. 1-3 and [35,36]). Genetic studies implicated Delta as a component 
of the Notch pathway but the direct molecular evidence for the role of Delta as a ligand 
came only in the mid 1990s from the labs of Artavanis-Tsakonas, Kopan, Israel, Simpson 
and Young. They showed that binding of Delta to Notch is required to activate Notch 
signaling [4,21-25,37,38]. Delta was also found to be cleaved by ADAM proteases 
[39,40] and this cleavage was shown to downregulate its signaling ability [41].  
Genetic analyses showed that E(Spl) acts downstream of Notch [42] using 
embryonic “neurogenic” phenotype as a read-out. Jarriault and Israel provided molecular 
evidence that intracellular domain of Notch activates gene transcription of the Enhancer 
of split complex [6]. This complemented immunostaining data for E(Spl) gene products 
showing that removal of Notch expression in embryos abolishes E(Spl) expression [7]. 
However, the link between Notch and E(Spl) is a lot weaker at later developmental 
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stages, such as the larvae [43]. It is likely that Notch has other targets in addition to 
E(Spl) but the identity of those genes is currently unknown (see discussion in the 
Appendix A and [44]). 
The field of Notch biology has attracted the attention of many researchers. The 
Notch pathway has proved to be a conserved mechanism of cell fate specification in all 
multicellular animals (metazoa). It is crucial for the development of almost all tissues 
(Table 1-2) and in general it links a fate of one cell to that of its neighbor [2]. Mutations 
in components of the Notch pathway are linked to multiple pathologies (Table 1-1 and 
reviewed in [2]). Disregulation of Notch signaling is seen in multiple forms of cancer 
(reviewed in [45]). As a result, manipulation of Notch signaling is being investigated as a 
possible therapeutic approach for treatment of these diseases [45]. 
 
1.4: Contexts of Notch signaling 
Notch signaling is active in all germ layers and is pleiotropic in its functions 
(summarized in Table 1-1 and [2,3]). In the nervous system, Notch signaling inhibits 
neuronal differentiation, promotes gliogenesis, regulates timing of myelination by 
oligodendrocytes, and regulates proliferation of neural stem cells [2,46]. A classic example 
of Notch signaling is the lateral inhibition in Drosophila neural-epidermal fate choice. 
During Drosophila embryogenesis about 2000 ectodermal cells form pro-neural clusters or 
neuroectoderm and gain the potential to become neuroblasts. About 500 cells choose neural 
fate and send the signal via Delta ligand to Notch receptors on adjacent cells to inhibit them 
from following the same fate. A failure of Notch signaling leads to “neurogenic phenotype” 
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where all 2000 cells adopt neural lineage at the expense of epidermoblasts (Fig. 1-2 and 
[17,47]). Notch activity that restricts cell fates is often referred to as “inhibitory Notch 
signaling” [3].  Similar “inhibitory” Notch signaling is employed in the development of 
Drosophila peripheral sensory organs, visceral and somatic musculature, intestine, and 
heart [48]. In vertebrates, this kind of Notch activity regulates neurogenesis and 
myogenesis [3].  
Notch can also induce new cell fates. An example of this “inductive” Notch 
signaling can be observed in Drosophila wing development where Notch signaling 
between dorsal and ventral compartments of the wing induces formation of a line of cells 
that later develop into wing margin [49]. Failure of Notch signaling leads to a loss of 
wing tissue giving the classic “notched” phenotype (Fig. 1-2). Other examples of 
“inductive” Notch signaling include germline proliferation in C.elegans and gliogenesis 
in mammals and Drosophila [3]. 
Recently, Notch has been implicated in biological processes that are not related to 
cell fate decisions. Notch can regulate both apoptosis and proliferation, often in the same 
tissue, but the mechanism of Notch action is still unknown (reviewed in [2]). Notch has 
also been shown to direct axonal outgrowth and this activity does not require activation 
of Notch transcriptional activity [50]. 
Finally, there are other contexts where Notch expression has been documented but 
its function is still elusive. For example, Notch is expressed in larval neuroblasts and their 
progeny (our observations and [51,52]) but the role of Notch signaling in these cells is not 
resolved. One model postulates that Notch regulates proliferation and differentiation of 
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neuroblasts [53]. However, other studies find that Notch function is dispensable during 
larval brain development [54].  
 
1.5: Overview of ADAM proteases  
A unique property of Notch pathway is the crucial role of ADAMs in initiating 
signaling. ADAM (a disintegrin and metalloprotease) proteases are type I transmembrane 
proteins of a metzincin class of metalloproteases whose proteolytic activity is coordinated 
by a Zn2+ metal ion, three histidines and one glutamate at a conserved active site with the 
conserved sequence HExxHxxGxxHD [55]. The sequence of ADAMs include an N-
terminal signal peptide followed by a prodomain, a metalloprotease domain with the 
catalytic site, a disintegrin domain, a cysteine-rich domain usually with EGF repeats, a 
transmembrane domain and a cytosolic tail (Fig. 1-3). The pro-domain keeps ADAMs in 
latent stage by a ‘cysteine switch’ mechanism (reviewed in [56]). Disintegrin and 
cysteine-rich domains mediate interactions with substrates and other proteins. Other 
members of metzincins include matrix metalloproteases (MMP) and ADAMTS (ADAM 
with thrombospondin domains) that function in remodeling extracellular matrix. Recent 
report implicated MMP-7 as the enzyme responsible for aberrant ligand-independent Notch 
activation in early stages of pancreatic cancer [57]. It remains to be seen if this enzyme is 
involved in non-pathological modes of Notch activation. So far, there is little or no 
evidence that ADAMTSs or other MMPs can influence Notch signaling.  
Over 40 ADAMs have been identified so far, most of them in mammals. About half 
of the ADAMs are expressed in testes and the rest are in various tissues [58]. However, 
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only about half of the proteases have catalytic activity. Functions of ADAMs include cell 
adhesion mediated by non-metalloprotease domains and proteolysis of many single pass 
transmembrane proteins including cytokines, growth factors, receptors, adhesion and other 
proteins (reviewed in [59]). ADAMs play important role in many biological processes 
including spermatogenesis, fertilization, inflammation, blood coagulation, cardiogenesis, 
and neurogenesis. In the nervous system, ADAMs are involved in cell migration, axon 
guidance, fasciculation, myelination, and signaling. ADAMs have been implicated in 
multiple pathologies including tumorgenesis, asthma, and Alzheimer’s [60]. In general, 
ADAMs can cleave many substrates and a particular substrate can be cleaved by more than 
one ADAM, albeit with different efficiency [59].  
Regulation of ADAMs is poorly understood and appears to be specific for 
individual proteases. The following mechanisms have been found to affect the activity of 
ADAMs: transcriptional control, alternative splicing, control of pro-domain cleavage, 
inhibition by TIMP (tissue inhibitors of matrix metalloproteases), selective trafficking and 
regulation of affinity for substrates [59,61]. 
In Drosophila, there are five known ADAMs: Kuzbanian (Kuz, an ADAM10 
ortholog); Kuzbanian-like (Kul, another ADAM10 ortholog); TNF-α converting enzyme 
(TACE, ADAM17 ortholog); Mind-meld (Mmd, ADAM9/14 ortholog); and Meltrin 
(ADAM12 ortholog) [62]. ADAM proteases exhibit a dynamic range of expression that 
varies depending on the developmental stage (Fig. 1-4) and cell type (see Chapter 4). 
Therefore, it can be inferred that Delta-Notch signaling occurs in contexts where individual 
ADAMs are expressed at different levels. 
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It should be noted that research on ADAMs has been done in diverse species, 
from nematodes to humans, and it is difficult to translate these findings from one animal 
to another. Even though sequences of ADAMs are conserved in many species, their 
functions seem to have diverged. Comparison of phenotypes of null mutations in 
homolog ADAMs highlights this point (Table 1-3). 
 
1.6: Proteolysis of Notch and Delta 
Normal development is very sensitive to the cell surface levels of Delta and Notch 
[63]. Two major mechanisms that regulate cell surface levels are proteolysis and 
endocytosis. Several proteases of the ADAM family can cleave both Notch and Delta. For 
example, Kuz cleaves both Notch and Delta. Whereas Kuz cleavage of Notch is usually 
activating, Kuz cleavage of Delta generally debilitates the ligand from interacting with 
Notch [41]. Therefore, these ADAMs have dual role: they can both promote and 
downregulate Notch signaling. Some ADAM proteases have selective preference for Delta 
versus Notch and this selectivity results in downregulation of Notch signaling. For 
example, Kul cleaves Delta but not Notch. As a result, Kul is suggested to maintain 
directionality of Notch signaling in contexts where Notch and Delta are co-expressed in the 
same cell [64]. However, with five Drosophila ADAM family members and more than 40 
mammalian homologs the potential for ADAMs to differentially modulate Notch signals 
has not been fully investigated. The following section provides an overview of individual 
ADAMs and their role in Notch signaling. 
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Kuzbanian. Several lines of evidence support the notion that Kuz acts on both 
Notch and Delta. Flies homozygous for loss of function mutation in Kuz fail to suppress 
neural cell fates and die at embryonic stage with a severe Notch-like neurogenic phenotype 
[65]. Genetic studies show that Kuz is required both in the Notch expressing (signal 
receiving) cells and in the Delta expressing (signal sending) cells and it acts upstream of 
the γ-secretase cleavage of Notch (NICD) [65-68]. Furthermore, extracellular domain of 
Notch appears to be necessary for Kuz to facilitate Notch activation [67]. Biochemical 
studies show that, in Drosophila S2 cells, Kuz and Notch can physically associate and Kuz 
is able to cleave a Notch construct with engineered truncations in the extracellular and 
intracellular domains [69]. Of note, most previous studies characterizing Notch cleavage 
have almost exclusively been carried out with constructs of overexpressed Notch carrying 
deletions of intracellular and/or extracellular domains to achieve ligand-independent 
activation and execute better resolution on SDS-PAGE. It remains to be seen if results of 
these studies can be validated with endogenous Notch.  Delta also undergoes Kuz-
dependent cleavage both in-vivo and in-vitro [40,64].  In-vivo studies show that 
overexpressed extracellular fragment of the cleaved Delta does not activate Notch 
suggesting that Delta cleavage downregulates its ligand activity [41]. It is still not known 
if preventing Delta cleavage will lead to increased Notch signaling and whether Kuz 
regulates Notch signaling primarily in signal sending or signal receiving cells. In chapter 
four of this dissertation, we show that Kuz has minimal effect on regulating Delta 
signaling capacity and acts primarily on the receptor in our in-vitro system.  
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TACE.  Experimental data is contradictory on the role of TACE in Notch activation. 
Biochemical studies show that in mice, TACE and not Kuz is required for  cleavage of 
various Notch1 constructs that are missing extracellular domain [32,70]. In Drosophila S2 
cells, overexpressed TACE can compensate for the loss of Kuz-dependent cleavage of 
Notch construct with engineered truncations in the extracellular and intracellular domains 
[69]. However, it is not clear if TACE cleaves endogenous Notch and if this cleavage 
activates it. In chapter four of this dissertation we show that TACE can both robustly cleave 
and activate Notch in-vitro. These facts are in contradiction with the phenotypic data from 
TACE null mice that do not exhibit neurogenic phenotypes akin with Notch mutations [71] 
whereas Kuz null mice do [72]. Overexpressed TACE can cleave Delta in Drosophila S2 
cells [64].  
Kul. The role of Kul in Notch activation is unclear. Biochemical evidence suggests 
that Kul can cleave a Drosophila Notch construct with engineered truncations in the 
extracellular and intracellular domains  [69]. These results are in contradiction with 
immuno-histological studies that show that manipulations of Kul levels have no effect on 
Notch distribution [64]. Overexpressed Kul can also cleave Delta in Drosophila S2 cells 
and affect Delta immunoreactivity in-vivo [64]. 
Meltrin. No studies have addressed interactions of Meltrin with Notch. Drosophila 
embryos homozygous for Meltrin mutations are lethal with uncharacterized phenotype 
[73]. Overexpressed Meltrin fails to cleave Delta in Drosophila S2 cells [64]. 
Mmd. Effects of Mmd on Delta or Notch cleavage have not been studied. Sequence 
analysis shows a substitution in a conserved active site amino acid, predicting that Mmd  
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is the only Drosophila ADAM that does not possess metalloprotease activity. Mmd is 
highly expressed in developing Drosophila central nervous system (CNS) [74] and 
mutations in this gene are lethal [75] with uncharacterized phenotype (B. Chase, personal 
communication [76]). In C.elegans, mutations in UNC-71, an ortholog of Drosophila 
Mmd, produce defects in axonal guidance and cell migration [77]. 
In mammals, Delta and Jagged were found to undergo γ-secretase dependent 
cleavage in addition to ADAM cleavage. Several research groups suggested that the 
cleavage of these ligands follows RIP model [78,79,80]. Since RIP of single-pass 
transmembrane receptors is a stereotyped mechanism to activate signaling, the remaining 
question is whether or not RIP of Delta is indicative of its receptor-like function. Binding 
of Delta to Notch in-trans (on the adjacent cell) promotes Delta cleavage. Furthermore, 
overexpressed intracellular fragment of Delta preferentially accumulates in the nucleus 
suggesting it might act as a receptor and have a signaling role [81]. However, in the 
second chapter of this dissertation we show that Drosophila Delta is not a substrate for γ-
secretase cleavage and generally does not follow the RIP model [82]. These results 
corroborate our findings that overexpressed intracellular fragment of Delta has no 
biological activity in-vivo (M. Rand, unpublished observations). It is still not known if 
mammalian Delta has any receptor-like function.  
 
1.7: Endocytosis of Notch and Delta 
The relationship between endocytosis and Notch signaling has been the subject of 
studies since early 1990-s (reviewed in [83]).  The first evidence that endocytosis is 
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required for Notch signaling came from endocytosis-deficient flies (shibirets) that showed 
neurogenic phenotypes similar to Notch [84]. Loss of endocytosis affects both signal 
sending and signal receiving cells [85]. On the signal receiving side, endocytosis is not 
required downstream of activated Notch [85] suggesting that endocytosis plays a role in 
Notch cleavage. One hypothesis is that ADAM-cleaved C-terminal product of Notch is 
endocytosed and undergoes γ-secretase dependent cleavage in endosomes.  Evidence in 
support of this hypothesis is conflicting, with some support coming from studies of 
truncated Notch2 in mice [86] but a lack of support from studies in Drosophila [87]. 
Currently, the exact mechanism that links Notch activation to endocytosis is not known. 
On the signal sending side, multiple research groups have shown that endocytosis 
of Delta is required for its signaling capacity [85,88-93]. Disabling Delta endocytosis in 
signal sending cells, either with shibirets dynamin mutation or by removing various 
components of endocytotic machinery (neuralized, mind-bomb, liquid facets, fat facets), 
leads to excessive accumulation of Delta on the cell surface and loss of Delta function. 
For endocytosis-mediated Delta signaling, there are several models. One model, termed 
“trans-endocytosis”, postulates that when Delta binds Notch, endocytosis of Delta creates 
a mechanical pull on the Notch receptor thereby exposing S2 cleavage site which is 
otherwise inaccessible [94]. This model came from studies of loss-of-function Delta 
allele, DlRF, that was also reported to be endocytosis-deficient [95]. In the third chapter of 
this dissertation, we refute this property of DlRF by providing evidence that DlRF never 
reaches cell surface [96] therefore questioning the validity of this model. Other models 
propose that endocytosis and later recycling to cell surface promotes maturation of Delta 
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through yet unidentified post-translational mechanism [90,97].  Another model postulates 
that endocytosis of Delta removes in-cis inhibition of Notch by Delta thereby allowing 
Notch to receive a signal [89], although this model does not explain cell non-autonomous 
effect when Delta endocytosis is prevented. Several reports also point to relationship 
between Delta endocytosis and proteolysis [88,90]. Removal of Liquid Facets ubiquitin 
ligase leads to lack of Delta endocytosis as well as disappearance of cleaved Delta [90] 
suggesting that endocytosis of Delta is required for Delta proteolysis. In contrast to this 
finding, we show in the second chapter of this dissertation that proteolysis of Delta is 
completely independent of its endocytosis and happens prior to it [82]. Overexpression of 
Neuralized E3 ubiquitin ligase in Drosophila larval wing disks leads to downregulation 
of Delta expression and Delta proteolysis [88]. Again, we report in the second chapter 
that removal of Neuralized expression in S2 Drosophila cells leads to overall decrease in 
the level of Delta protein, consistent with increased Delta endocytosis and turnover. 
However, the removal of Neuralized does not lead to change in Delta cleavage, 
confirming that Delta cleavage is independent of Delta endocytosis [82]. 
Despite multiple lines of evidence that endocytosis is required for Notch signaling 
in-vivo, results from in-vitro studies fail to show such requirements. Notch can be 
effectively activated by Delta that cannot undergo endocytosis. For example, formalin 
fixed Delta expressing cells can effectively activate Notch in live cells (chapter four of 
this dissertation and [41]), and so can extracellular domain of Delta that is immobilized to 
beads or a plastic surface [98] and reviewed in [83]) or clustered with an antibody 
[99,100,101]. 
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Altogether, contradictory results in published studies demonstrate a lack of clear 
understanding of how endocytosis regulates Notch signaling. 
 
1.8: Other mechanisms of Notch regulation 
In addition to proteolysis and endocytosis, there are a number of other 
mechanisms that regulate Notch signaling.  
Notch and its ligands can be transcriptionally regulated. Earlier studies found 
that Delta is transcriptionally repressed by the E(Spl) genes that act downstream of Notch 
activation [102]. This mechanism, though, does not explain how directionality is initially 
established since both Notch and its ligands are equally expressed on signal sending and 
signal receiving cells. In some contexts, such as gonadal development in C.elegans, it has 
been shown that stochastic variations in the levels of these proteins lead to transcriptional 
amplification of Notch in one cell and Delta in adjacent cell [103]. Later studies found 
this feedback mechanism to be less generalized than initially expected. Forced uniform 
expression of Delta and Notch in proneural ectoderm did not affect segregation of neural 
and epidermal cell fates [104]. Therefore, in many contexts there are other post-
transcriptional mechanisms that regulate directionality of Notch signaling. 
Affinity of Notch for its ligands can be modified. Fringe, a glycosyltransferase, 
glycosylates Notch on select EGF repeats and makes it more responsive to Delta and less 
responsive to Serrate signals [105]. Numb, an adaptor protein, can bind to intracellular 
domain of Notch and prevent it from activation. Numb is selectively inherited by one of 
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sensory organ precursor (SOP) daughter cells and this protein is responsible for 
directionality of Notch signaling between these cells [46].   
Notch and its ligands can be selectively presented on the cell surface. O-
fucosyltransferase-1 (OFUT1) fucosylates Notch on select EGF repeats and controls its 
surface presentation. In the absence of OFUT1, Notch fails to reach the surface and 
receive a signal from neighboring cells [106].  
Other signaling pathways can bias directionality. The presence of redundant 
multiple E(Spl) proteins and pleiotropy of Su(H) allow Notch signaling to be modulated 
by other signaling pathways. This combinatorial mechanism provides a way to tailor 
Notch response to the appropriate developmental context [3]. In invertebrates, Notch has 
been found to interact with all major signaling pathways (reviewed in [2]). Cooperation 
of epidermal growth factor (EGF) and Notch pathways is required for correct cell fate 
specification in developing Drosophila eye [107] and wing vein [108] (reviewed in 
[109]). In vertebrates, myogenesis and endothelial cell migration depend on the interplay 
between Notch and TGF-β pathways, and crosstalk between Notch and Wnt pathways is 
important in somitogenesis, hematopoiesis and skin tumor development. Interaction 
between Notch and JAK/STAT pathway is required for correct glial differentiation [2]. 
Delta and Notch can antagonize each other. Delta and Serrate can act as 
inhibitors of Notch receptor if they are co-expressed with Notch in the same cell (in-cis) 
at high levels [110,111,112]. High levels of in-cis Notch can also prevent Delta from 
sending a signal [112]. This mechanism helps to establish directionality of Notch 
signaling in the Drosophila wing margin [110] and is probably involved in other contexts 
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where Notch signaling contributes to boundary formation [113]. Consistent with this 
model, we report in the second chapter that Delta cleavage is upregulated upon binding to 
Notch in-cis pointing to a mechanism by which in-cis inhibition of Notch by Delta can be 
modulated [82]. 
 
1.9: Summary and questions addressed in the dissertation.  
Delta-Notch signaling plays crucial role in both normal and pathological 
development. Therefore, molecular details of this pathway is of great interest to both basic 
and translational scientists. In my dissertation work, I focused on how proteolysis and 
endocytosis of receptor and ligand regulate Notch signaling. This section summarizes the 
rationale and open questions that were addressed in this dissertation. 
Proteolysis of Delta in mammals follows a stereotyped pattern of cleavages, termed 
RIP (regulated intramembrane proteolysis). We addressed two open questions: (a) Is RIP 
mechanism conserved in Drosophila Delta?; and (b) What is the identity of proteases 
acting on Drosophila Delta? 
Proteolysis of Delta is hypothesized to downregulate its signaling capacity. 
Consistent with this hypothesis, overexpressed soluble extracellular domain of Delta lacks 
biological activity. Does preventing Delta cleavage lead to an increase in Delta signaling 
capacity and consequent increase in Notch activation?  
Kuz, one of five Drosophila ADAMs, cleaves both Delta and Notch.  Given that 
Kuz can have both activating and downregulating affect on Notch signaling, does Kuz 
regulate Notch activation by preferentially acting on the receptor or on the ligand?  
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TACE, another Drosophila ADAM, has been shown to cleave an artificial construct 
of Notch. Will TACE cleave native Notch at endogenous expression levels and will TACE-
dependent cleavage of Notch lead to its activation? 
Endocytosis of both Notch and Delta has been shown to be required for Notch 
signaling. Several in-vivo studies have shown that Delta endocytosis and proteolysis are 
linked. Is endocytosis of Delta required for its proteolysis in-vitro?  
Evidence for the requirement for Delta endocytosis in Notch signaling came from 
in-vivo studies of DlRF mutant allele that was initially characterized as endocytosis 
deficient. However, definitive proof that DlRF fails to be endocytosed has been lacking. 
Does DlRF fail to be endocytosed in an in-vitro system where endocytosis can be assayed 
accurately?  
In many contexts in-vivo, Delta and Notch are co-expressed in the same cell 
prompting questions how directionality of Notch signaling is established. One model 
proposes that Delta acts as in-cis inhibitor of Notch and selective removal of Delta leads 
to increased availability of Notch receptors and greater signal receiving capacity. Is 
proteolysis of Delta affected by binding to Notch in-cis?.  
My approach to and results of investigating these questions are detailed in the 
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Table 1-1. Notch signaling and human pathologies. 
(modified table from [2]) 
Notch pathway 
element 
Nature of mutation  Disease and associated 
pathology  
Notch 1  
 
Rare chromosomal translocations 
(<1%); missense or frame shift 
mutations in the extracellular and/or 
PEST domain (>50%) 
Acute T-cell lymphoblastic 
leukaemias 
 
Notch 1 Nonsense or frameshift mutations 
leading to truncated transcripts 
Aortic valve disease 
 
Notch 3  
 
Missense mutations affecting cysteine 
residues in epidermal growth factor 
repeats 
CADASIL; autosomal 
dominant; late onset arterial 
smooth muscle cell 
degeneration 
Jagged 1  
 
Frameshift or splice donor site 
mutations; rare large deletions 
Alagille syndrome; 
autosomal dominant; 









Lunatic fringe  
 






Table 1-2. Developmental processes that are regulated by Notch signaling. 
(adopted from [3]) 
C. elegans D. melanogaster Vertebrates 
Regulation of early 
blastomere specification 
Regulation of AC/VU 
decision 
Regulation of vulval 
precursor fates 
Induction of left-right 
asymmetry 
Induction of germline 
proliferation 
 
Inhibition of neurogenesis 
Regulation of gliogenesis, neural 
lineage fates 
Inhibition of wing venation 
Inhibition of myogenesis, 
cardiogenesis 
Inhibition of midgut precursors 
Induction of mesectoderm 
Induction of wing margin 
Induction of leg segments 
Induction of dorsoventral eye 
polarity 
Induction of cone cells in the eye 
 
Inhibition of neurogenesis 
Regulation of fate choices in the 
inner ear 
Inhibition of non-neural ectodermal 
derivates (Xenopus ciliated cells, 
chick feather buds) 
Inhibition of myogenesis, 
cardiogenesis 
Induction of left-right asymmetry 
Regulation of limb bud development 
Regulation of somitogenesis 
Regulation of lymphopoiesis 
Regulation of vascular development 
Regulation of hematopoiesis 





Table 1-3. Comparison of phenotypes caused by null mutations in ADAMs.   
Mice data are from [59]. Drosophila data are from references cited in the text. N/A, data not 
available. 
Genotype ADAM name Phenotype in mice Phenotype in 
Drosophila 
 Mice Drosophila   
adam9 -/- Meltrin-γ Mind-meld? Viable, fertile, no obvious 
pathology 
See adam14 -/- 
adam10 -/- Kuzbanian Kuzbanian 
Kuzbanian-like 
Embryonic lethal (E9.5), defective 
heart and CNS development, 
vasculogenesis and 
somitogenesis; defective Notch 
signaling 
Embryonically lethal with 
Notch phenotype [65] 
adam12 -/- Meltrin-α Meltrin Viable, fertile, grossly normal; 
high post-natal death rate; minor 





Adam14 -/- N/A Mind-meld N/A Lethal with 
uncharacterized 
phenotype [76] 
adam17 -/- TACE TACE Perinatal lethal; general epithelial 
dysgenesis, defective heart and 
lung development, deficient 
ectodomain shedding 
N/A 










Split (Mβ, Mγ, etc.)














Figure 1-1. Delta-Notch signaling pathway.  
Upon binding to Delta on an adjacent cell, Notch receptor undergoes an activating cleavage at S2 site by 
proteases of the ADAM family to produce NEXT fragment followed by the γ-secretase cleavage at S3 site 
to produce NICD fragment. NICD binds to Suppressor of Hairless and regulates transcription of Enhancer 
of Split genes. Notch activation is very sensitive to the level of Delta ligand on the cell surface. Cell surface 
levels of Delta can be regulated by proteolysis and endocytosis.  Endocytosis sequesters available Delta 
from the cell surface thereby diminishing signal sending capacity. Proteolysis of Delta by ADAM proteases 
disables its ligand activity. Therefore, ADAMs cleave both the ligand and the receptor. Whereas Notch 
cleavage leads to its activation, the cleavage of Delta disables its ligand activity. Another model of Delta 
proteolysis postulates that cleavage of Delta leads to release of cytosolic fragment of Delta that can signal 











Figure 1-2. Phenotypes associated with mutations in the Drosophila Notch.  
 
(A) Loss-of-function mutations in the notch gene produce notches in the wings of adult flies. Top panel: 
wings of wild-type Drosophila flies. Bottom panel: wings of Drosophila flies that carry loss-of-function 
mutations in the notch gene (Notch-). (B) Notch signaling is required to segregate neural and epidermal cell 
fates during neurogenesis in Drosophila. Loss of Notch signaling leads to excessive number of cells adopting 
neural fate at the expense of epidermal fate. Top panel: nervous system of wild-type Drosophila embryo. 
Bottom panel: embryos with Notch null mutations fail to segregate neural and epidermal fate and most cells 
adopt neural lineage. Nervous system is stained with antibody against horseradish peroxidase (a marker of 

















Figure 1-3. Structure of Notch, Delta and ADAMs.  
 
Notch protein is a 2703 amino acid (300KDa) single-pass type I transmembrane protein. Its extracellular 
domain encodes 36 tandem epidermal growth factor (EGF)-like repeats and 3 cysteine-rich Notch/LIN-12 
repeats (LNR). The intracellular domain contains 6 tandem ankyrin repeats, 1 glutamate-rich domain (opa), 
and 1 PEST sequence [19,20]. Delta is an 880 amino acid single-pass type I transmembrane protein. Its 
extracellular domain contains a Delta-Serrate-ligand (DSL) domain and 9 EGF-like repeats [35,36]. 
ADAMs are single-pass type I transmembrane proteins. Their sequence includes a prodomain, a 
metalloprotease domain with the catalytic site, a disintegrin domain, a cysteine-rich domain usually with 
EGF repeats, a transmembrane domain and a cytosolic tail. The pro-domain keeps ADAMs in latent stage 
by a ‘cysteine switch’ mechanism (reviewed in [56]). Disintegrin and cysteine-rich domains mediate 







Figure 1-4. Developmental dynamics of expression.  
 
Levels of expression of ADAM genes in Drosophila at various stages of development as determined by 
microarray transcriptional profiling. Each row represents the progression of development determined at 66 
time points. The color scale shows enrichment of expression (yellow) or downregulation of expression (blue) 
as compared to the average expression across all 66 points [114]. Kuz and TACE show dynamic upregulation 
in the embryonic stages. Aside from a spike of TACE expression in early larval stage, Kuz and TACE 
expression is relatively unchanged during this stage.  Kul and Meltrin show dynamic changes during 





CHAPTER 2:  




Material from this chapter has been published in the following form: 
Delwig, A., Bland, C., Beem-Miller, M., Kimberly, P. and Rand, M.D. (2006). 
Endocytosis-independent mechanisms of Delta ligand proteolysis. Experimental Cell 





Delta proteins function as cell surface ligands for Notch receptors in a highly 
conserved signal transduction mechanism.  Delta activates Notch by “trans-endocytosis”, 
whereby endocytosis of Delta that is in complex with Notch on a neighboring cell 
induces activating cleavages in Notch.  Alternatively, proteolysis of Delta renders the 
ligand inactive by dissociating the extracellular and cytosolic domains.  How proteolysis 
and trans-endocytosis cooperate in Delta function is not well understood.  We now show 
that Drosophila Delta proteolysis occurs independent of and prior to endocytosis in 
neuroblasts and ganglion mother cells in-vivo and cells in culture.  Delta cleavage occurs 
at two novel sites that we identify in the juxtamembrane (JM) and transmembrane (TM) 
domains.  In addition to the previously identified Kuzbanian ADAM protease, which acts 
on the JM domain, proteolysis in the TM domain is facilitated by a thiol-sensitive 
aspartyl protease that is distinct from Presenilin.  Furthermore, cleavage in the TM 
domain is upregulated in the presence of Notch.  Overall, Drosophila Delta proteolysis 
differs from the conventional regulated intramembrane proteolysis (RIP) mechanism by 
two criteria: 1) TM-domain processing of Delta is not sensitive to Presenilin, and 2) TM 
and JM domain cleavages occur independent of each other.  Altogether, these data 
support a model whereby proteolysis can modulate Delta ligand activity independent of 






The Delta ligand is type-I single pass transmembrane protein that is essential for 
dictating cell fate decisions during development in a number of organ systems in 
metazoans [1, 2].  Analyses of Drosophila neurogenesis established early on that Delta 
acts predominantly as a ligand for Notch receptors in a highly conserved signal 
transduction mechanism that mediates cell-cell communication [1].  It is now understood 
that Delta-Notch signaling is ubiquitous in development, being fundamental to cell fate 
decisions in both neural and non-neural tissues [3, 4].  As a result, the molecular 
mechanisms of this pathway have been the subject of intensive research.  
Delta-Notch signaling is highly responsive to the post-translational events of 
endocytosis and proteolysis [5-10].  The existing data support a “trans-endocytosis” 
model whereby endocytosis of Delta, when bound to Notch on a neighboring cell, 
induces activation of the Notch receptor (reviewed in [5]).  In this model, the molecular 
strain conferred upon Notch by Delta “trans-endocytosis” serves to expose cleavage sites 
for proteolytic activation of Notch [11].  The fact that the Notch extracellular domain 
product is found co-localized with Delta in endocytic vesicles in Delta expressing cells is 
evidence in favor of this model [11, 12].  Furthermore, analyses of the Drosophila 
dynamin mutant, known as Shibire, show that endocytosis is required in Delta expressing 
cells to mediate Notch signals [13].  Additional evidence for the trans-endocytosis model 
comes from identification of the E3 ubiquitin ligases known as Neuralized and Mind-
bomb.  These ligases mediate ubiquitin transfer to the Delta cytosolic domain, which 
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promotes subsequent endocytosis and increased ligand activity [14-16].  However, since 
Delta endocytosis proceeds constitutively in most cells and tissues, it is unclear how 
ligand activity could change in response to the need to modulate Notch signals. 
Delta proteins also undergo proteolysis, which separates the Notch-binding 
extracellular domain from the cytosolic domain and endocytosis machinery [6, 8].  As a 
result, cleavage is a potential means of downregulating ligand activity [17].  Consistent 
with this hypothesis the soluble Delta extracellular domain (Dlec) products resulting from 
cleavage have proven inactive as Notch ligands [17], unless artificially tethered to a 
substrate [18].  In a mechanism that is incongruous with the trans-endocytosis model, 
Delta proteolysis can be upregulated through interactions with Notch [7, 10].  
Nonetheless, a recent study correlates Delta proteolysis with an endocytic process that 
parallels ligand activation [19].  As a result, the role of Delta proteolysis in the trans-
endocytosis model remains obscure, leaving several questions as to how endocytosis 
influences proteolysis of Delta and whether proteolysis of Delta is significant in-vivo.  
Recent reports indicate Delta processing follows a mechanism of regulated 
intramembrane proteolysis (RIP), which was first described for the proteolytic activation 
of Notch.  The RIP mechanism requires sequential cleavage steps to occur within the 
juxtamembrane (JM) and transmembrane (TM) domains, which are carried out by an 
ADAM metalloprotease and the Presenilin γ–secretase, respectively (reviewed in [20]).  
Since, in the case of Notch and a growing number of membrane receptors, RIP serves to 
release a cytosolic signaling domain that has activity in the nucleus [21-23], new 
hypotheses for a receptor function for Delta have evolved [7, 8, 10].  However, a nuclear 
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function for Delta in a relevant biological context remains to be demonstrated and thus it 
is uncertain if Delta is a substrate for a classical RIP mechanism.  
Despite recent advancements, the mechanism of Delta cleavage is not completely 
understood.  Drosophila Delta proteolysis produces three distinct cell-associated products 
termed DlcdP1, DlcdP2 and DlcdP3 [7]. DlcdP1 arises from cleavage in the JM domain 
by the Kuzbanian (ADAM10) metalloprotease.  This cleavage is consistent with a site 
identified at Ala581 [7, 17].  DlcdP2 is generated by a yet-to-be identified protease, but is 
consistent with a site identified at Ala593 at the JM-TM domain interface [7, 17].  The 
cleavage site for DlcdP3 also remains unidentified, but is predicted to map to the TM 
domain [7].  As well, the “P3” enzyme has yet to be identified, but the predicted TM 
domain cleavage points to Presenilin.  The mammalian Notch ligands, mouse and rat 
Delta1, rat Jagged1, and human Jagged2, are processed to give at least two C-terminal 
products, analogous to DlcdP1 and DlcdP3 [8-10].  Similar to Drosophila Delta, Mouse 
Delta1 is processed in part by ADAM10 in the JM domain.  While several lines of 
evidence indicate Presenilin is required for a second subsequent cleavage [8-10], the TM 
domain cleavage site for mouse Delta1 awaits identification.  Further analysis of the 
Delta cleavage mechanism has been necessary to resolve the nature and activity of the 
Delta products. 
 In this study we show that a significant fraction of Drosophila Delta is 
proteolytically processed independent of and prior to endocytosis, thereby influencing the 
Delta available for trans-endocytosis of Notch.  Furthermore, we show that Delta 
proteolysis is significantly upregulated when co-expressed with Notch in the same cell.  
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We also determine that Delta proteolysis occurs at two sites in the JM and TM domains, 
respectively, that are distinct from previously reported sites.  Proteolysis requires 
Kuzbanian-dependent metalloprotease activity and a novel thiol-sensitive aspartyl 
protease activity.  In addition, we show that Delta proteolysis differs from the RIP 
mechanism by two fundamental criteria: 1) TM-domain processing of Delta is not 
sensitive to Presenilin, and 2) TM and JM domain cleavages occur independent of each 
other.  Overall our data support a model whereby proteolysis can act to modulate ligand 
activity prior to trans-endocytosis and activation of Notch.  
 
2.3: Material and methods 
 
Chemicals and reagents - p-aminophenylmercurial acetate (APMA), Aprotinin, 
phenylmethylsulphonyl fluoride were from Sigma (St Louis, MO).  
P(chloromercuri)benzylsulphonate (PCMBS) and p(chloromercuri)benzoic acid (PCMB) 
were from Toronto Research Chemical (Toronto, Canada).  TAPI-1, GM6001, MG-132, 
Leupeptin, Pepstatin, MDL-28170, L-685,458 and N-ethylmaleimide, were from 
Calbiochem (EMD Bioscience, San Diego, CA).  DFK167 was obtained from MD 
Bioscience (St. Paul, MN).  All other reagents were of the highest research grade.  
 
Cloning and expression constructs -  Assays of Delta cleavage were conducted 
with both stable and transiently transfected Drosophila S2 cells.  For transient expression 
of full-length Drosophila Delta both the pIZDl and pIZDlV5 plasmids were used, which 
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encode Drosophila Delta without or with an inframe C-terminal V5 epitope, respectively 
[7].  Drosophila DlcdP1 construct encoding amino acids 582-833 and containing 
endogenous stop codon was PCR amplified with primers 5'-
CGGCATGCAAGCGAGAGCCGATGGTTTG-3' and 5’-
CCGCTCGAGTTACATATGCGGAGTGCCGCAG-3’ and cloned into SphI/XhoI site in 
pMIB/V5-HisA vector (Invitrogen).  Endogenous Thr582 and Thr583 are replaced with 
Gly(582) and Met(583) in the DlcdP1 construct to accommodate inframe cloning with the 
signal sequence. For expression of Neuralized protein a combination of the actin-GAL4 
plasmid (pA5C, gift from Tom Kornberg, UCSF) and the pUAS-Neuralized (gift from 
Eric Lai, U. of California, Berkeley) was used.  The pUAS-CD8GFP plasmid was a gift 
from Liquin Luo (Stanford University).  Transfections were done with the Cellfectin 
reagent (Invitrogen). 
 
Antibodies - The mouse monoclonal C594.9B, specific for the extracellular 
domain of Drosophila Delta, was a gift from Spyros Artavanis-Tsakonas (Harvard 
Medical School, also available a the Developmental Studies Hybridoma Bank, University 
of Iowa).  Antibodies were raised against a purified fraction of the entire cytosolic 
domain of Drosophila Delta.  The region encoding amino acids 619-833 of Drosophila 
Delta (Dlic) was cloned in-frame with a poly-His N-terminal tag into the pRSETB vector 
(Invitrogen).  Protein was expressed in BL21 bacteria induced with IPTG according to 
manufacturer’s protocols (Invitrogen).  Protein was purified from bacterial lysates using 
Probond nickel sepharose chromatography (Invitrogen).  The His-tagged Dlic protein was 
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used for immunization of rats for monoclonal antibody production and chickens for 
polyclonal antibody production. Rat monoclonal antibodies were produced through the 
services of Maine Biotechnology Services (Portland, ME).  ELISA screening was done 
using the His-Dlic protein.  Delta-specific clones were additionally screened by Western 
blotting with untagged Delta and by immunostaining of larval Drosophila tissues.  
Several clones were isolated and the clone designated 10D5 was used for this study.  
Purified IgY fraction of chicken polyclonal antibodies to the Dlic protein were produced 
through the services of AVES Labs (Tigard, OR).    
 
Immunostaining - Central nervous system of third instar Drosophila larvae were 
dissected in phosphate buffer-saline (PBS), rinsed twice in PBS, and fixed in 2% 
paraformaldehyde in PBS for 20 minutes.  Tissues were permeabilized with 1% triton-X 
100, 1% normal goat serum (NGS) in PBS for one hour.  Primary antibody was prepared 
in 0.1% Triton-X 100, 1% NGS in PBS and samples were incubated at 4°C for 16-24 
hours.  After two 30 minute washes in 0.1% TX-100, 1% NGS, PBS, samples were 
incubated in fluorescence-conjugated secondary antibody for 2-4 hours at room 
temperature or 4°C for 16-24 hour.  This step was followed by two 30-minute rinses in 
PBS and immersion in Citifluor mounting medium (University of  London).  The tissues 
were mounted under a coverslip that was elevated by flanking coverslips to minimize 
compression.  Cultured Drosophila cells were stained by the same method except that 
incubations were for two hours in primary antibody at room temperature and one hour in 
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secondary antibody at room temperature.  Images were captured using a Nikon C1 
confocal microscope system and processed using Adobe Photoshop software (Adobe). 
 
Cell culture and protein expression -  Drosophila S2 cells and the Dl-S2 and N-
S2 cell lines (Gift from Spyros Artavanis-Tsakonas, Harvard Medical School) were 
routinely cultured at 25-27°C as previously described [7].  Drosophila EH34A3 Shibire 
temperature sensitive mutant cells and ML-DmBG3-C3 cells were obtained from the 
Drosophila Genome Resource Center (Bloomington, IN) and cultured at 22-23°C in 
Sang’s M3 medium (JRH Biosciences, Lenexa, KS) with 12.5% fetal bovine serum 
(FBS) and bactopeptone (2.5g/L) and yeastolate (1g/L) (1X BPYE) supplement (Difco) 
and insulin (10µg/ml).  Expression in Drosophila S2 cells and in EH34A3 cells was done 
through transient transfection using the Cellfectin reagent (Invitrogen, Carlsbad, CA).  
Alternatively DL-S2 cells were induced to express Delta with 0.1mM CuSO4 as 
previously described [7]. Transfections were done according to the following protocol: 
healthy growing cells were plated into a tissue culture plate and allowed to adhere until 
60-70% confluent. Media is then aspirated and replaced with transfection mix. 
Transfection mix is made by adding 0.46% (v/v) plasmid DNA and  3% (v/v) cellfectin to 
plain insect media without serum.  Cells are rocked for 4 hrs at room temperature. 
Transfection mix is then aspirated and full media is added. Cells are allowed to recover 
and express plasmid for 16-40 hours prior to assays.  
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Amino acid sequencing – DlcdP1, DlcdP2 and DlcdP3 product were isolated by 
immunoaffinity chromatography using the 10D5 anti-Delta antibody coupled to CNBR-
Sepharose (Amersham) by standard protocols.  The Delta products were isolated from 
lysates prepared from untreated and 200µM APMA treated DL-S2 cells.  Lysis buffer 
consisted of 50mM Tris, 1% IGEPAL CA-630 (Sigma, St. Louis, MO), 150mM NaCl 
containing the protease inhibitors EDTA (5mM), PMSF (2mM), Aprotinin, Leupeptin 
and Pepstatin (5µg/mL each).   Lysates were preadsorbed with non-immune rat IgG-
sepharose prior to isolation with the affinity resin. Eluted proteins were resolved by SDS-
PAGE and transferred to PVDF membranes (Milipore).  N-terminal sequence analysis 
was performed through the services of the W. M. Keck Biotechnology Resource 
Laboratory (Yale University, New Haven, CT). 
 
RNA interference -  RNA interference (RNAi) was done essentially as reported 
previously for Kuzbanian RNAi [7, 24].  Templates for in-vitro synthesis of double 
stranded RNA (dsRNA) for Presenilin used T7-linked primers to PCR amplify a fragment 
encompassing bp1048-1536 of Drosophila Presenilin cDNA.  Similarly, a template for 
Neuralized RNAi was generated with T7-linked primers to PCR amplify a fragment 
encompassing bp289-780 of the Neuralized cDNA where bp289 is the start codon of the 
open reading frame.  Drosophila cells were incubated with dsRNA for 3 days prior to 
transfection and expression of Delta.  Protein levels of Presenilin were assayed by 
Western blotting (see below) using rabbit polyclonal antibody to the Drosophila 
Presenilin C-terminal fragment (gift from Cedric Wesley, Univ. of Vermont).  Activity of 
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transfected Neuralized was verified by treatment of transfected of cells with increasing 
amounts of Neuralized RNAi and incubation for 48 hours followed by the assay of Delta 
cleavage and expression. 
 
Delta cleavage assays – Delta cleavage products were analyzed in lysates of Delta 
expressing cells (see lysis buffer above).  Samples were run on 12% SDS-PAGE and 
Western blotted by standard procedures using antibodies to the Delta intracellular domain 
or V5 epitope described above.  Proteins were visualized by peroxidase-labeled 
secondary antibodies using standard chemiluminescent detection or by using IRDye700 
or IRDye800 conjugated secondary antibodies (Rockland) and a Li-Cor Odyssey scanner 
(Li-Cor, Lincoln, NE).  For assays in Notch-S2 cells (Gift from Spyros Artavanis-
Tsakonas, Harvard Medical School), pIZDL [7] was transfected and cells were recovered 
overnight.  The cells were then plated to six wells and treated with 0, 44, 88, 175, 350 
and 700µM CuSO4 for 16hours to induce Notch expression at various levels.  Cells were 
harvested and lysed for Western  blotting using the Chicken anti Dlic domain antibody.  
CuSO4 in the medium had no effect on Delta expression or proteolysis (data not shown).  
Assays involving inhibitors or activators of Delta cleavage were carried out in serum-free 
M3 culture medium.  Inhibitors or thiol reactive compounds (or dimethylsulfoxide 
(DMSO) solvent controls) were added to the medium at the indicated concentrations and 
cells were incubated for four hours prior to lysis.  The activity of Neuralized was assayed 
by co-transfection of pIZDLV5, pA5C and pUAS-Neuralized (or pUAS-CD8GFP as 
control) in S2 cells and recovery for 48 hours.  To assay the role of endocytosis Delta-
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transfected EH34A3 cells (or control S2 cells) were incubated at 30°C (or 22°C control) 




Immunolocalization of Delta cleavage products.  In order to characterize the 
cleavage products of Delta in Drosophila tissues and in cell culture, we have probed for 
the Delta cytosolic domain (Dlcd) and extracellular domain (Dlec) simultaneously using 
the 10D5 rat monoclonal and the C594.9B (9B) mouse monoclonal antibodies, 
respectively.  We have probed the proliferative centers of the ventral surface of the 
thoracic ganglion of third instar Drosophila larvae where there is an abundance of Delta 
and Notch expressing neuroblasts (NBs) and their daughter cells (ganglion mother cells, 
GMCs) (see Fig. 2-1A and Fig. 2-3A).  Previous studies in Drosophila, in both neural and 
non-neural tissues, have shown that Delta localizes predominantly in endocytic vesicles, 
in keeping with the requirement of ligand endocytosis for Notch receptor activation [11, 
25].  We see that Delta is similarly localized to vesicles in larval NBs and their GMCs 
(Fig. 2-1B).  This pattern is analogous to that previously described by Kooh, et al [25].  
However, we observe an unexpected distribution of Dlcd and Dlec domains to separate 
vesicles revealed by the independent “red” and “green” immunoreactivity (Fig. 2-1B and 
C). The independent Dlcd- and Dlec-containing vesicles represent a significant portion of 
the Delta-containing vesicles suggesting that a considerable fraction of the total Delta 
undergoes proteolysis in these neural precursor cells.  In addition, many vesicles display 
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a “yellow” signal indicative of immunoreactivity of both antibodies with either uncleaved 
Delta or Dlcd and Dlec products that co-segregate to the same vesicle.  These data 
support a model whereby proteolysis dissociates the Dlec and Dlcd domains, which are 
then segregated to different endocytotic compartments (see Fig. 2-1E).   
To determine whether cleavage of Delta is a fundamental posttranslational 
processing event, we investigated whether a similar segregated distribution of Dlcd and 
Dlec occurs in cultured Drosophila cells that stably express Delta.  Delta protein levels in 
the DL-S2 cell line exceeds that seen in NBs or GMCs in-vivo as seen by the 
accumulation of Delta on the plasma membrane (Fig. 2-1D).  This is consistent with the 
fact that in this over-expression system a majority of the Delta protein remains uncleaved 
as indicated by Western blot analysis of cell extracts (See Fig. 2-2 below).  Despite the 
high levels of uncleaved Delta, segregation of Dlcd and Dlec products is observed in Dl-
S2 cells (Fig. 2-1D).  Intracellular vesicular bodies are seen that stain specifically for the 
Dlcd domain with no apparent staining for the Dlec (Fig. 2-1D).  Correspondingly, the 
Dlec is seen to accumulate in concentrated domains at the cell surface, suggesting that 
this domain has a tendency to aggregate, either by itself or with other cell- or matrix-
associated proteins.  The lower level of Dlec-positive vesicles in these cells may be due 
in part to the ability of the Dlec product to diffuse away after cleavage and escape uptake 
in endocytic vesicles in culture conditions.  Overall, these data are consistent with a 
model whereby proteolysis by a fundamental mechanism that is endogenous to 
Drosophila cells serves to dissociate Dlec and Dlcd (Fig. 2-1E).   
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Delta processing and endocytosis – The transendocytosis model of Notch 
activation predicts that dissociation of the Dlec and Dlcd domains would uncouple ligand 
endocytosis from receptor activation.  However, a recent study suggests a role for 
endocytosis in a proteolytic activation step of the ligand [15] raising the question of how 
endocytosis and proteolysis are linked.  To investigate this relationship we examined the 
propagation of the Dlcd cleavage products in the Drosophila EH34A3 cell line that 
carries a temperature sensitive mutant allele of Shibire (Shits), the Drosophila dynamin 
homolog [11].  At the restrictive temperature (30°C) dynamin in these cells is rendered 
non-functional and pinching off of clathrin coated endocytic vesicles from the membrane 
ceases.  The effectiveness of these cells in preventing Delta endocytosis is seen in Figure 
2-2A and has been demonstrated previously [11].  Using Western blot analysis of cell 
lysates, we see that Delta expressed in Shits cells maintained at the permissive 
temperature (23°C) shows a profile of C-terminal derived cleavage products consisting of 
DlcdP1, DlcdP2 and DlcdP3 as previously described (Fig. 2-2B, and see [7]).  The profile 
of Delta proteolysis is unchanged in Shits cells at the restrictive temperature (Fig. 2-2B), 
indicating that internalization of endocytic vesicles has no effect on formation of the 
Delta products.  Furthermore, these data demonstrate that the full complement of Delta 
cleavage can occur prior to endocytosis.  In comparison, we see that the overall levels of 
full-length Delta and the Dlcd cleavage products expressed in S2 cells are reduced at 
30°C compared to S2 cells maintained at 23°C (Fig. 2-2B), consistent with a general 
upregulation of endocytosis and degradation of Delta in the S2 cells at the elevated 
temperature.  Despite this increase in overall Delta degradation in S2 cells, no significant 
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change the relative amounts of full-length Delta and Dlcd cleavage products is observed, 
indicating that endocytosis has little effect on Delta proteolysis. 
We further explored the possibility that upregulated endocytosis could alter Delta 
processing using the Neuralized E3 ubiquitin ligase.  Neuralized promotes ubiquitination 
and endocytosis of Delta in Drosophila cells [15].  In control experiments, co-expression 
of Delta together with a CD8-GFP protein control in S2 cells results in a normal profile 
of Delta processing consisting of primarily the DlcdP1 and DlcdP2 products (Fig. 2-2C, 
lane 1).  Co-expression of Delta with Neuralized shows a concomitant decrease of full-
length Delta and the DlcdP1/DlcdP2 products (Fig. 2-2C, lane 2), thereby confirming that 
Neuralized acts to reduce overall Delta levels, presumably through upregulated 
endocytosis and degradation.  However, we see no significant change in the amount of 
Dlcd products relative to full-length Delta (Fig. 2-2C, lane 2).  The specificity of 
Neuralized activity was verified by targeted reduction of Neuralized mRNA using 
interfering RNA (RNAi) in the Delta/Neuralized transfected cells.  Increasing amounts of 
Neuralized RNAi results in a return of full-length Delta and DlcdP1/P2 to control levels 
(Fig. 2-2C, lanes 3, 4).  Altogether, the results from the Shits cells and Neuralized co-
expression experiments demonstrate that proteolytic processing of Delta occurs 
independent of, and prior to, endocytosis of the ligand. 
 
Notch-induced proteolysis of Delta.  The significant level of segregated Dlec and 
Dlcd vesicles seen in NBs and GMCs suggests Delta proteolysis occurs with relatively 
high efficiency in these cells.  Yet, proteolysis is not driven by endocytosis, raising the 
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question as to what promotes Delta proteolysis in this context.  We have previously 
shown that Notch-Delta interaction in trans (between adjacent cells) in culture induces 
Delta proteolysis [7].  Examination of Notch expression in thoracic ganglion NBs and 
GMCs in-vivo shows a high level of colocalization with Delta, not only between NBs and 
their GMCs but also within the same cells (Fig. 2-3A, also see [25]).  This observation 
suggests that both cis (within the same cell) and trans interactions of Notch and Delta 
prevail in these cells.  To examine the influence of cis interactions of Notch-Delta in 
greater detail, we transfected a Delta expressing plasmid into the Notch-expressing S2 
cell line (N-S2).  Notch expression in these cells is regulated by the metallothionein 
promoter and can thus be incrementally induced to high levels by addition of copper to 
the culture media.  With increasing expression levels of Notch, we observe a robust 
accumulation of the DlcdP3 product, with a decrease in DlcdP1 (Fig. 2-3B).  
Correspondingly, full-length Delta is decreased, consistent with the hypothesis that Notch 
is effective in inducing Delta proteolysis through cis interactions.  It should be noted that 
in this culture system, while cis interactions are favored, trans interactions are also able to 
occur and therefore this result does not definitively distinguish either interaction as being 
solely responsible for Delta cleavage (see Fig. 2-3C).  Nonetheless, this system mimics 
the possibility for both cis and trans interactions that occur in the NB-GMC cluster in-
vivo.  Altogether, these data indicate that Delta proteolysis is likely to occur at high levels 
in the context of Delta-Notch signaling in the developing central nervous system, thereby 
highlighting the importance of these cleavages in Delta-Notch signaling.   
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Identification of Delta cleavage sites.  To further characterize the proteases 
involved, we have identified the cleavage sites in the Delta polypeptide.  Using affinity 
purification with the anti-Dlcd monoclonal antibody (10D5), we isolated the DlcdP1, 
DlcdP2 and DlcdP3 products from Dl-S2 cell extracts.  Direct N-terminal sequence 
analysis was performed on protein immobilized on PVDF membrane.  Interestingly, both 
the DlcdP1 and DlcdP2 products gave the same N-terminal sequence beginning at His577 
(Fig. 2-4A and C).  This result confirms that cleavage occurs in the JM domain at the C-
terminal side of Ala576, five amino acids distal to the previously identified Ala581 site.  
The DlcdP3 N-terminal sequence was found to begin at Val600, indicating cleavage 
occurs on the C-terminal side of Ala599, which falls within the transmembrane domain, 
five amino acids from the extracellular face (Fig. 2-4A and C).  The pattern of Delta 
cleavage depicting our current analysis is illustrated in Fig. 2-3B.  The observation that 
DlcdP1 and DlcdP2 share the same N-terminus indicates these products likely differ in 
their C-terminus or other modification to the cytosolic domain.   
 Differences between the sites identified here and the previously identified sites 
at Ala581 and Ala593 may reflect additional proteolytic processes that occur in the Dlec 
product.  Different analytical methods have been employed in each case.  The Ala583 and 
Ala591 sites were identified by determining the C-terminal composition of two Dlec 
products [17].  Here, we have employed direct N-terminal sequence analysis of the Dlcd 
products.  One possibility is that an initial cleavage at Ala599 generates a Dlec product 
that is labile and undergoes additional cleavage at Ala593 and Ala581.  While the 
contribution of each cleavage site to the overall kinetics of Delta proteolysis warrants 
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additional study, our current data clearly identify an intramembranous cleavage site, 
thereby providing rationale for future studies aimed at identifying the protease involved.   
For comparison, the cleavage sites of several type-1 transmembrane proteins 
known to be cleaved by ADAM proteases and Presenilin are illustrated in Figure 2-4C.  
Cleavage sites in the juxtamembrane (JM) domains of Drosophila Delta, mouse Delta1, 
mouse Notch1 and human APP fall within a region 10-18 amino acids external to the 
plasma membrane, consistent with the sites of cleavage mediated by ADAM proteases 
[26].  With exception of the S4 site in Notch, the majority of Presenilin-dependent 
cleavage sites map to the middle and C-terminal regions of the TM domains of the Notch 
and APP proteins (Fig. 2-4C), and similarly in E-Cadherin, ErbB-4, CD44 and Syndecan 
3 (not shown, [27-30]).  In contrast, cleavage at Ala599 in Drosophila Delta is oriented in 
N-terminal region of the TM domain (Fig. 2-4C), suggesting that it is either a divergent 
site of Presenilin cleavage or arises from an alternative protease activity.   
 
Protease activities required for Delta cleavage in the juxtamembrane domain.  
The Kuzbanian ADAM protease is required for cleavage of Delta in the juxtamembrane 
domain [6].  To characterize the enzymatic cleavage of Delta further, we have examined 
several small molecule inhibitors of specific classes of proteases.  For these analyses, we 
were able to favor the formation of DlcdP1 while also producing detectable DlcdP3 by 
treatment with 50µM p-aminophenylmercuric acetate (APMA) [7].  DlcdP2 is seen to 
occur at relatively unchanged steady state levels with and without APMA.  From our N-
terminal sequence data, we predict that both DlcdP1 and DlcdP2 result from Kuzbanian–
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dependent Delta processing and therefore metalloprotease inhibitors would abolish 
formation of both DlcdP1 and DlcdP2.  However, we have previously shown that knock 
down of Kuzbanian in S2 cells results in selective inhibition of DlcdP1 formation while 
DlcdP2 is unaffected [7].  To test whether a related ADAM protease mediates the DlcdP2 
cleavage, we examined the activity of the hydroxamic acid-based metalloprotease 
inhibitor GM6001.  GM6001 is highly effective at inhibiting DlcdP1 product formation 
(Fig. 2-5A).  In addition, TAPI-1, a well-characterized inhibitor of the TACE (ADAM 
17) protease [31], showed potent inhibition of DlcdP1, consistent with the role for 
ADAM proteases in generating this product.  Unexpectedly, neither GM6001 nor TAPI-1 
affected formation of DlcdP2 (Fig. 2-5A, also see Fig. 2-7A).  These data suggest that 
DlcdP2 arises from a proteolytic activity that cleaves at the same site as Kuzbanian, but is 
of a different class.  Overall, we find that DlcdP2 levels change very little with either 
APMA-mediated induction or with any of the inhibitors examined thus far including 
metallo-, aspartyl-, serine and cysteine protease inhibitors (data not shown) bringing to 
question the nature of the proteolytic activity required for “P2” cleavage.  One possibility 
is that DlcdP2 processing occurs in a subcellular compartment that is inaccessible to 
APMA and/or the small molecule inhibitors we have examined thus far.  Nonetheless, 
these data distinguish that distinct enzymes are required for DlcdP1, DlcdP2 and DlcdP3 
production.  Importantly, these data also suggest that, in contrast to the requisite 
sequential cleavages of Notch in the RIP mechanism, DlcdP1 is not a prerequisite for 
subsequent DlcdP2 or DlcdP3 formation.   
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To examine a possible sequential mechanism of cleavage further, we created a 
truncated form of Delta mimicking the DlcdP1 product for expression in the S2 cell 
system.  We find that the recombinant DlcdP1 is resistant to proteolysis, even in the 
presence APMA (Fig. 2-5B).  Very low amounts of DlcdP3 product are seen with 200µM 
APMA; however, compared to the robust proteolysis of full-length Delta seen with 
200µM APMA (Fig. 2-5B, lane 2), we conclude that DlcdP1 is a stable intermediate.  
Furthermore, immunostaining of DlcdP1-expressing S2 cells shows that DlcdP1, like 
full-length Delta, is present on the plasma membrane, as well as in intracellular vesicles 
(Fig. 2-5C), and is therefore likely to be exposed to the relevant enzymes capable of 
processing full-length Delta.  These data demonstrate that DlcdP1 is not a suitable 
substrate for further processing to the “P3” product, and therefore Delta processing does 
not follow a sequential cleavage model.  These data also indicate that DlcdP3 product 
arises predominantly through direct cleavage of full length Delta in the transmembrane 
domain.  
 
Presenilin-independent cleavage of Delta.  Using the γ–secretase-specific 
aspartyl protease inhibitor DFK-167 [32], we observed inhibition of DlcdP3 formation 
(Fig. 2-6A), consistent with the hypothesis that Presenilin is required for DlcdP3 
formation.  However, the L-685,458 inhibitor, a potent and specific inhibitor of 
mammalian Presenilins [33], showed inconclusive results with inhibition of both DlcdP3 
and DlcdP1 formation at low concentrations (0.5-2 µM) and promotion of DlcdP1 
formation at high concentration (50µM, data not shown).  Furthermore, MDL28170, also 
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an effective γ-secretase inhibitor [34], showed no activity in preventing DlcdP3 formation 
(Fig. 2-6A).  RNAi targeting Presenilin is highly effective at depleting Presenilin mRNA 
(not shown) and protein from Drosophila S2 cells (Fig. 2-6B, lower panel).  However, 
DlcdP3 formation is unchanged with RNAi knockdown of the Presenilin protein (Fig. 2-
6B) indicating that Presenilin does not play a role in the “P3” cleavage of Delta.  In 
contrast, application of Kuzbanian RNAi is extremely effective in preventing DlcdP1 
formation (Fig. 2-6B, lane 3 and in [7]), thereby confirming the effectiveness of the 
RNAi methodology in this system.  Altogether, these data demonstrate that Drosophila 
Delta undergoes cleavage at the DlcdP3 site by an activity that is not sensitive to 
Presenilin activity, but responsive to an aspartyl protease inhibitor.   
We also observe that Delta cleavage is not altered by MG132 (Fig. 2-6A), a 
potent inhibitor of ubiquitinated protein degradation and proteosome function [35], again 
confirming that Delta processing is not a result of a general protein degradation 
mechanism.  As well, the potent activity of MDL28170 toward calpain inhibition [36] 
and its inactivity in inhibiting Delta cleavage (Fig. 2-6A) further suggests that Delta 
proteolysis is not a by-product of programmed cell death.   
 
Thiol sensitive induction of Delta TM domain proteolysis.  In our system, we can 
induce Kuzbanian activity with APMA to produce DlcdP1 [7].  This activity of APMA is 
consistent with mercury-thiol interactions that are known to relieve “cysteine-switch” 
propeptide inhibition in ADAM metalloproteases [37, 38].  Yet, with APMA we also 
observe a concentration-dependent formation of the DlcdP3 product [7].  We therefore 
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asked whether the intramembranous DlcdP3 cleavage is influenced by APMA directly.  
This was achieved by first preventing formation of DlcdP1 using GM6001 to effectively 
inhibit Kuzbanian activity (Fig. 2-7A).  Upon addition of APMA, in the presence of 
GM6001, we observed a dramatic increase in DlcdP3 production with a concomitant 
decrease in full-length Delta (Fig. 2-7B).  No significant increase in DlcdP1 or DlcdP2 is 
observed, further confirming that DlcdP3 does not arise through a sequential cleavage 
mechanism.  These data also support the hypothesis that the P3 cleavage in Delta is 
sensitive to thiol modification, presumably via mercurial-cysteine interaction.  To test 
this hypothesis further, we examined the activity of the thiol-specific reagent N-
ethylmaleimide (NEM), which is a covalent modifier of sulfhydryl groups of unpaired 
cysteine residues [39].  In the presence of GM6001, we observe a concentration 
dependent increase in DlcdP3 formation with NEM (Fig. 2-7C), similar to that seen with 
APMA, confirming that the general property of thiol modification results in upregulated 
proteolysis of Delta at the “P3” site.   
To further distinguish the “P3” enzyme from Kuzbanian, we next asked whether 
the sensitive thiol in this mechanism resided in the extracellular or intracellular 
environment.  APMA and NEM are both membrane-permeable compounds and thus can 
potentially modify cysteine residues in both the extracellular and cytosolic compartments 
as well as within the lipid bilayer.  To distinguish where cysteine modification is 
occurring we examined the activity of two related organomercurials, p-
(chloromercuri)benzenesulfonic acid (PCMBS) and p-(chloromercuri)benzoic acid 
(PCMB).  These compounds have been previously shown to selectively act on cysteine 
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residues in the extracellular or cytosolic/lipid bilayer compartments in a manner 
consistent with their membrane permeability properties [40].  PCMBS is membrane 
impermeable due to a highly charged sulfonic acid group (pKa=~1.5, Fig. 2-7D).  In 
contrast, the weakly acidic carboxyl group of PCMB (pKa~4, Fig. 2-7D) allows for a 
protonated fraction at physiological pH, which is lipid-soluble and membrane permeable.  
We find that PCMBS promotes DlcdP1 formation at higher concentrations (1 mM); 
however, it does not promote DlcdP3 formation (Fig. 2-7D).  In contrast, 1mM PCMB 
effectively promotes DlcdP3 formation (Fig. 2-7D), consistent with the hypothesis that 
DlcdP3 cleavage is actively promoted by modification of cysteine(s) in the cytosolic or 
lipid bilayer compartment.  PCMB also promotes DlcdP1 formation indicating that like 
PCMBS, PCMB can activate latent Kuzbanian through an extracellular cysteine switch 
mechanism.  Altogether, these data identify a unique proteolytic activity that acts on the 
Delta TM domain.  This protease displays a novel mechanism of upregulating 
intramembrane proteolysis through modification of cysteine residue(s) in transmembrane 
and/or cytosolic domains of proteins. 
 
2.5: Discussion 
The relevance of Delta cleavage to the Notch signaling mechanism has remained 
unresolved.  One principal finding of this study is that the Dlec and Dlcd products of 
Delta processing sort to different vesicles in the neuroblasts and ganglion mother cells of 
the developing Drosophila central nervous system.  Furthermore, we demonstrate that 
proteolysis of Delta proceeds independent of endocytosis, and can be upregulated through 
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interactions with Notch.  Together these data demonstrate that, at a cellular location 
where Delta-Notch signaling is predominant, a significant level of Delta proteolysis 
occurs which segregates the ligand binding extracellular domain from the cytosolic 
domain which engages with the endocytotic machinery.  At face value, a mechanism that 
promotes ligand degradation upon receptor binding is not congruous with the trans-
endocytosis model of Notch signaling.  These data, nonetheless, suggest that the integrity 
of the Delta ligand is tightly regulated, emphasizing the central role of proteolytic 
mechanisms in Delta activity. 
In the instance where interaction of Notch with Delta on a neighboring cell results 
in Delta proteolysis, subsequent activation of Notch by Delta endocytosis would be 
defeated.  It follows that Delta must avert proteolysis to effectively activate Notch.  
Signaling could rely on a basal level of Delta that happens to escape proteolysis.  
However, due to the abundance of Dlec and Dlcd products seen in NBs and GMCs, we 
predict that an additional means of diverting Delta from proteolysis is required to 
appropriately modulate Delta-Notch signaling.  One possibility is that Delta proteins 
destined to activate Notch are sorted to a compartment that is segregated from the 
relevant proteases.  In support of such a sorting mechanism, two recent reports document 
selective trafficking of Delta in Rab11-positive recycling endosomes, which facilitates 
Notch signaling in sensory organ precursors in Drosophila [41, 42].  The explicit effect 
of this sorting event on Delta proteolysis remains to be investigated.  Wang, et al. [19] 
propose that targeting of Delta to an endocytic compartment, which requires Neuralized 
and the Drosophila Epsin homolog, is required for conversion to active ligand.  However, 
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Wang et al. [19] also find overexpression of Delta together with Neuralized results in 
Delta proteolysis, which in contrast to our findings and is counter-intuitive to generating 
and active ligand.  Our studies demonstrate that halting endocytosis altogether with the 
Shibire dynamin mutant has no significant effect on the steady state level of Delta 
cleavage.  It follows that if Delta cleavage does occur in endocytic compartments, it 
likely acts on a very small fraction of the total ligand population.  Further studies aimed 
at determining the integrity of Delta within subcellular compartments will define how a 
sorting mechanism could regulate ligand activity through proteolysis.   
Delta processing has been reported to follow the RIP mechanism that acts on 
Notch and APP.  In the canonical RIP mechanism an ADAM metalloprotease cleavage in 
the JM domain precedes a Presenilin-mediated cleavage in the TM domain [43, 44].  In 
the case of Notch, APP and a growing number of type-1 transmembrane proteins, 
cleavage results in translocation of a cytosolic fragment to the nucleus [44].  We now 
show that Drosophila Delta does not adhere to the RIP paradigm.  Consistent with RIP, 
the Delta JM domain cleavage is mediated by the ADAM Kuzbanian.  But unlike RIP, 
the TM domain “P3” cleavage can occur independent of the JM domain cleavage.  In 
addition, we find the “P3” cleavage is not sensitive to knock down of Presenilin 
expression with RNAi.  On this note, we cannot exclude the possibility that the trace 
amounts of Presenilin that remain after RNAi treatment are sufficient for normal levels of 
“P3” processing in our system.  However, the same RNAi methodology is highly 
effective at inhibiting Presenilin processing of Drosophila Notch [45].  We also find the 
Delta TM domain cleavage site is divergent from several of the known Presenilin 
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substrate sites.  Cleavage of Delta at Ala599, just five residues into the TM domain, 
leaves a majority of the TM domain intact, making it possible that the DlcdP3 product 
stays resident in the membrane bilayer.  This predicted outcome is consistent with the 
fact that we fail to observe Dlcd immunoreactivity in the nucleus of cells in-vivo (AD and 
MDR, unpublished observation).  While Mouse and rat Delta1 adhere more closely to the 
RIP mechanism [8, 10], the TM cleavage site in these mammalian homologs has yet to be 
determined.  In addition, evidence for endogenous mouse Delta1 translocating to the 
nucleus is lacking. Thus, it remains to be seen if Delta proteolysis results in a biologically 
relevant nuclear activity.   
Proteolysis may impact an alternative cell autonomous function of Delta.  Delta 
interaction with Notch on the same cell effectively inhibits Notch signals [46], 
presumably through formation of non-productive receptor-ligand complexes.  Mishra-
Gorur, et al. [17] initially proposed a model whereby Kuzbanian serves to clear Delta 
from the cell surface, making Notch accessible for signals coming from neighboring 
cells.  This model is supported by recent data characterizing a Kuzbanian homolog, 
Kuzbanian-like (Kul), which processes Delta in a similar fashion and contributes to 
unidirectional Notch signaling [47].  Our data indicates that in addition to cleavage by 
Kuzbanian (and Kul), processing of Delta at the “P3” site could achieve the same goal of 
separating Dlec and Dlcd.  Importantly, we demonstrate that co-expression of Delta with 
increasing levels of Notch can upregulate the “P3” cleavage.  This latter observation 
suggests that, in the context of neural development, elevated Notch expression is 
accompanied by clearance of Delta from the same cell, thereby reinforcing the ability of 
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that cell to receive signals through Notch.  However, it remains to be shown if Notch-
induced cleavage of Delta results from direct trans- or cis- interaction of the proteins, or 
alternatively, through an indirect mechanism that requires Notch activity.  Regardless of 
the mechanism, our observations emphasize the importance of the “P3” intramembranous 
cleavage of Delta as a regulatory mechanism for Notch signals.  
We have gained some insight into the nature of the “P3” protease using thiol 
reactive organomercurial compounds, which are able to mimic Notch-induced Delta 
cleavage.  Using PCMBS and PCMB, we distinguish that the thiol target for activating 
the “P3” cleavage lies within the plasma membrane and/or in cytosolic compartments.  
One possible mechanism is that the thiol target is a cysteine residue in Delta itself and 
modification by organomercurials renders Delta more susceptible to cleavage at the P3 
site.  This possibility remains to be tested through mutagenesis and TM domain swapping 
experiments.  An alternative hypothesis is that thiol modification is targeted to the 
protease that acts on Delta.  A precedent for this latter mechanism occurs in human 
Presenilin in which the first transmembrane domain of the enzyme contains a conserved 
cysteine (Cys92) residue.  Interestingly, alteration of Cys92 by mutation to Serine as 
identified in a familial Alzheimer’s Disease patient has been shown to alter the enzyme’s 
activity causing an increase in β–amyloid products [48, 49].  It follows that perturbation 
of a TM domain Cys residue by APMA could act to upregulate the ”P3” enzyme 
responsible for Drosophila Delta cleavage.  Several Presenilin-like candidates have been 
identified in the Drosophila genome including the multipass transmembrane aspartyl 
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proteases of the signal peptide peptidase family [50].  Activity of these proteases in Delta 
processing is currently under investigation.  
Of importance to human health, the susceptibility of ADAM proteases, and the 
novel thiol-sensitive “P3” protease identified here, to organomercurial compounds 
highlights potential mechanisms of action for organomercurials encountered in the 
environment, such as the preservative Thimerosol and methylmercury.  Of particular 
note, methylmercury is a potent toxin that preferentially causes damage to the developing 
fetal nervous system resulting in significant cognitive and motor deficits [51-53].  
Preliminary experiments demonstrate a similar efficacy of APMA, Thimerosal and 
methylmercury in inducing Delta proteolysis (M.D.R, unpublished observation).  The 
fundamental role of Delta in neural development and its response to organomercurial 
compounds presents important new hypotheses for the toxic mechanism of 
methylmercury in the environment.    
In summary, we propose a model whereby Delta signaling can be modulated by a 
proteolytic mechanism that can act independent of sequestration of Delta to the endocytic 
pathway.  Within this model, Notch can act to promote Delta proteolysis directly.  
Scission of Delta occurs either in the JM or TM domain and is mediated either by 
Kuzbanian or an intramembranous protease, respectively.  Cleavage at either site is 
predicted to give the same net result: dissociation of the Dlec and Dlcd products thereby 
uncoupling the receptor-binding domain from the endocytosis machinery.  The 
consequence of Delta cleavage is that Notch activation fails.  Inhibition of Delta 
cleavage, potentially through sorting of Delta away from its proteases, would serve to 
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upregulate ligand activity.  This model therefore provides for a means of modulating 
Notch signals through enzymatic regulation of Delta ligand integrity.  Further 
identification and characterization of the proteases involved in Delta processing is 
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products of cleaved Drosophila Delta; Dlcd, Delta cytosolic domain containing product; 
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Figure 2-1. Localization and processing of Delta in neural cells.   
 
A) Schematic of the Drosophila larval central nervous system (CNS).  Anterior is to the left and dorsal is at 
the top.  The ventral nerve cord consists of the thoracic and abdominal ganglia.  The disproportionate 
enlargement of the thoracic ganglion reflects the numerous neurons that develop in these segments to 
process sensory and motor function in the adult fly.  Proliferative centers, consisting of a neuroblast (NB) 
and its associated daughter cells (ganlion mother cells, GMCs) populate the ventral and lateral surface of 
the thoracic ganglia, as well as other regions of the brain and optic lobes (not illustrated).  These 
proliferative centers express high levels of Notch and Delta on both the NBs and GMCs (see Fig. 3A 
and[25].  B) Subcellular localization of Delta products is seen in larval Drosophila CNS whole mount 
preparations stained with antibodies against the Dlcd (10D5, red) and Dlec (9B, green).  Images were 
collected by confocal microscopy at the ventral surface of the thoracic ganglion (red rectangle in A).  The 
NBs and GMCs of the proliferative centers are shown in panel B (box in B seen enlarged in panel C).  
Vesicles with distinct staining for Dlcd (red arrows), Dlec (green arrows) or both Delta domains (yellow 
arrows) can be seen.  D).  Delta-S2 cells stained with 10D5 (red), 9B (green) and DAPI (nuclear stain, 
blue).  Colocalization of staining is seen at the plasma membrane (yellow arrow).  Intracellular vesicles are 
predominantly positive for the Dlcd (red arrows).  Dlec is seen to accumulate in distinct domains on the 
extracellular surface (green arrows).  E).  A model to explain the vesicular distribution of Delta.  Two fates 
of Delta occur subsequent to presentation at the cell surface:  In (a), endocytosis recruits full length Delta 
and Delta escapes proteolysis;  In (b) proteolysis dissociates the Dlcd and Dlec, and subsequent uptake of 






































Figure 2-2. Delta processing occurs independent of and prior to endocytosis. 
 
A).  Confocal images of the dynamin mutant EH34A3 (Shits) cells transfected to express Delta, seen at the 
permissive temperature (23ºC) or the restrictive temperature (30ºC).  Cells were fixed and stained with 9B 
anti-Dlec antibody.  Delta is seen to accumulate in vesicles at the permissive temperature but is retained at 
the membrane surface when dynamin is disabled at the restrictive temperature.  B).  Western blotting of cell 
lysates with 10D5 antibody shows no significant change in the Delta cleavage profile with inhibition of 
endocytosis in the Shits cells at 30°C.  A reduction in total Delta (i.e. full-length Delta (Dl) and the cleavage 
products, DlcdP1 and DlcdP2) is seen at 30°C in Delta expressing-S2 cells indicative of upregulated 
endocytosis at elevated temperature.  C).  Lysates of S2 cells co-transfected with Delta-V5, together with 
Neuralized or a CD8GFP control (see methods), were analyzed by Western  blotting with anti-V5 antibody.  
Neuralized is seen to reduce the total Delta (i.e. full-length Delta (Dl) and the cleavage products) without 
changing the relative amount of cleavage products (lane 2).  Delta levels are seen to return to control levels 
with increasing amounts of Neuralized RNAi which specifically abolishes the Neuralized expression (lanes 
















Induction of Notch expression
 
Figure 2-3. Notch-induced cleavage of Delta 
 
A).  Immunostaining of the proliferative centers of the ventral thoracic ganglion (see Fig. 1A) for Notch 
(red) and Delta (Green) show significant co-localization in neuroblasts (NBs) and ganglion mother cells 
(GMCs).  B).  Lysates of Notch-S2 cells expressing transfected Delta were analyzed by Western  blotting 
with  anti-Dlcd (10D5) (bottom two panels) and anti-Notch (upper panel) antibodies.  Expression of Notch 
at incrementally increasing levels (upper panel) shows a decrease in full length Delta (Dl, middle panel) 
and a corresponding accumulation of the DlcdP3 product (lower panel).  C).  A model for Notch-induced 
Delta proteolysis:  Delta-Notch complexes that form either in cis- or in trans- orientation can result in 
proteolysis of Delta.  
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Figure 2-4. Cleavage sites in Delta and related proteins. 
 
A).  The DlcdP1, DlcdP2 and DlcdP3 products isolated from APMA-treated Dl-S2 cell extracts were 
immobilized on PVDF membranes and visualized by Coomassie-blue staining (upper panel).  The N-
terminal residues of the DlcdP1, DlcdP2 and DlcdP3 products were determined by Edman degradation and 
amino acid analysis (see methods).  “x” indicates the inability to identify the amino acid in the first cycle of 
the DlcdP1 and DlcdP2 sequencing reactions.  B).  A schematic for the Delta cleavage products derived 
from the cleavage sites identified in this study.  C).  Sequence alignment of several proteins known to 
undergo ADAM and γ-secretase cleavages. TM domain is shown in bold, EGF domain sequences are 
underlined, and regions known to undergo ADAM and γ-secretase cleavages are in grey boxes.  
Arrowheads point to  identified cleavage sites in Drosophila Delta (dDl) (this study and [17]), mouse 
Delta1(mDl1) [8], mouse Notch1 (mNotch1) [20, 54], human amyloid precursor protein (hAPP) [55].  
Cleavage of Drosophila Delta in the TM domain falls outside of the region of sites determined for 






















Figure 2-5. Non-sequential cleavage of Delta. 
 
A).  Western blot analysis of lysates of S2 cells expressing Delta-V5 and treated with 50µM APMA (to 
favor production of the DlcdP1 fragment while also producing DlcdP3).  Treatment with metalloprotease 
inhibitors GM6001 (25µM) or TAPI-1 (20µM), are compared to solvent control (DMSO).  Both inhibitors 
are highly effective at preventing formation of DlcdP1 (*) but show no effect on subsequent formation of 
DlcdP2 and DlcdP3.  B).  A truncated form of Delta representing DlcdP1 expressed in S2 cells is treated 
with increasing amounts of APMA and shows that DlcdP1 is resistant to cleavage.  C).  Immunostaining 
(with anti-Dlcd antibody) of S2 cells expressing the DlcdP1 construct shows localization of the protein to 































Figure 2-6. Presenilin independent processing of Delta. 
 
A). Western blot analysis of lysates of S2 cells expressing Delta-V5 and treated with 50µM APMA (to 
favor production of the DlcdP1 fragment while also producing DlcdP3).  Treatment with the inhibitors 
DFK-167 (200µM), MDL28170 (25µM), or MG132 (25µM) were compared to DMSO treated controls.  
DlcdP3 product (*) formation is inhibited by DFK-167.  B).  Delta-S2 cells were treated with Presenilin or 
Kuzbanian RNAi as indicated.  Cell lysates were analyzed by Western blotting with anti-Dlcd chicken 
polyclonal antibody.  Lower panel shows a Western  blot of the same cell lysates with an anti-Presenilin 
antibody directed toward the C-terminal fragment (CTF) of mature Presenilin (second lane).  Presenilin 
RNAi results in nearly complete depletion of Presenilin protein and no corresponding decrease in DlcdP3.  














































Figure 2-7. The DlcdP3 Cleavage is induced by thiol modification. 
 
In Panels A-D the top panel shows full-length Delta (Dl) and bottom panel shows cleaved products of 
Delta.  A).  Treatment of cells with GM-6001 (50µM) shows complete inhibition of DlcdP1 formation (*).  
B).  Pre-treatment of cells with GM6001 (50µM) followed by increasing amounts of APMA (structure 
shown at left) shows an increase in DlcdP3, indicating APMA induces the “P3” cleavage directly.  C).  Pre-
treatment of cells with GM6001 (50µM) followed by increasing amounts of N-ethylmaleimide (NEM, 
structure shown at left) shows increase in DlcdP3 analogous to APMA, confirming that thiol modification 
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is an underlying mechanism.  D).  Treatment of cells with increasing amounts of cell-impermeable PCMBS 
and cell permeable PCMB (structures shown below).  An increase of DlcdP3 is achieved only with the cell-
permeable PCMB, indicating that the sensitive thiol lies within the lipid bilayer and/or cytosolic 
compartment.  The unrelated structures of APMA and NEM are shown to highlight the different chemistry 
of thiol modification.  APMA forms a tight non-covalent thiol-mercury complex, while NEM form a stable 
covalent thioether with protein thiols.  The related structures of PCMBS and PCMB are shown which differ 
in their sulfonate and carbonate groups, respectively, as discussed in the text.   
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CHAPTER 3:  
LOSS-OF-FUNCTION IN THE DELTARF ALLELE IS DUE TO A FAILURE OF 
THE DELTA PROTEIN TO REACH THE CELL SURFACE.  
 
 
Material from this chapter has been published in the following form: 
Delwig, A. and Rand, M.D. (2007). Loss-of-Function in the DeltaRF Allele Is Due to a 




In current models of Notch signaling, endocytosis of the Delta ligand is a required 
step prior to or during Notch activation.  One line of evidence that supports these models 
comes from the studies of a temperature-sensitive loss-of-function DlRF allele that 
reportedly fails to undergo endocytosis.  Here we show that in Delta expressing larval 
neurons the DlRF protein fails to localize to neurites consistent with a failure in trafficking 
to the plasma membrane.  We find that the DlRF allele carries two mutations, G305E and 
C348Y, in the extracellular epidermal growth factor-like (EGF) repeats EGF3 and EGF4. 
Co-expression of GFP-tagged DlRF and RFP-tagged wild-type Delta (DlWT) in S2 cells 
demonstrates complete segregation of subcellular localization of the proteins at 30ºC with 
DlRF failing to localize to the plasma membrane.  A functional assay of antibody uptake 
reveals that DlRF protein does not reach cell surface.  As well, DlRF fails to undergo a 
characteristic proteolytic processing.  Altogether the data indicate that the DlRF is a 
misfolded protein that fails to reach cell surface and instead accumulates in perinuclear 
region.  Therefore, DlRF allele has limited utility for studying Delta endocytosis 
mechanisms but remains well suited as a tool for loss-of-function studies. 
 
3.2: Introduction 
Delta-Notch signaling is a fundamental pathway that controls cell fates during 
development.1  Temperature-sensitive loss-of-function alleles of Delta have been 
instrumental in determining the role of Delta during development.2-6  One of these alleles, 
DlRF (FBal0029364), was successfully used to map the function of Delta during larval 
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and pupal stages.2  These same alleles have contributed to understanding the molecular 
mechanisms of ligand induced Notch receptor activation.  For example, DlRF protein 
reportedly fails to be endocytosed6 and has been used to establish the model of Notch 
activation by “trans-endocytosis”, whereby endocytosis of the Delta ligand promotes 
subsequent proteolysis and activation of the Notch receptor on an adjacent cell.7  Delta 
endocytosis is central to an alternative model whereby epsin-dependent recycling of 
Delta is necessary for “activation” of the ligand, a step that may also lead to proteolytic 
processing.8-10  The unusual behavior of DlRF prompted us to investigate the underlying 
molecular lesion and the trafficking properties of the protein in more detail.  We now 
show that the DlRF fails to reach the cell surface, as seen by its accumulation in the 
perinuclear region and in large cytosolic vesicles and by its inability to uptake a Delta-
extracellular domain specific antibody.  Our data refutes the “endocytosis mutant” model 
of DlRF and supports a model whereby DlRF is a temperature sensitive misfolding protein 
that fails to traffic to the plasma membrane at a restrictive temperature.   
 
 
3.3: Methods and materials 
Sequencing and cloning DlRF allele. DlRF allele was PCR amplified from 3rd 
instar larvae genomic DNA and cDNA with Delta gene specific primers and then 
sequenced (sequencing performed by automated DNA sequencer at the Vermont Cancer 
center). The DlRF coding sequence was cloned into pIZ/V5-His vector (Invitrogen) with a 
GFP tag at the C-terminus. Wild-type Delta (DlWT) was cloned into pIZ/V5-His vector 
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with a GFP or a monomeric red fluorescent protein (RFP) tag at the C-terminus.  
Comparison of cellular localization of DlWT with or without fluorescent tags by 
immunocytochemistry reveals that these tags do not affect trafficking properties of Delta. 
 
Antibodies. Primary antibodies: mouse monoclonal C594.9B, specific for the 
extracellular domain of Drosophila Delta, a gift from Spyros Artavanis-Tsakonas 
(Harvard Medical School, also available a the Developmental Studies Hybridoma Bank, 
University of Iowa); and rat monoclonal 10D517, specific for intracellular domain of 
Drosophila Delta; mouse monoclonal 414 (Covance, cat. No: MMS-120R) that 
recognizes nuclear pore complex proteins. Secondary antibodies: goat anti-rat IRDye700 
(Rockland, Gilbertsville, PA) and goat anti-mouse Alexa680, goat anti-mouse Alexa555, 
and goat anti-rat Alexa488 (Molecular Probes). 
 
Immunostaining. Central nervous system of third instar Drosophila larvae were 
dissected in phosphate buffer-saline (PBS), rinsed twice in PBS, and fixed in 2% 
paraformaldehyde in PBS for 20 minutes.  Tissues were permeabilized with 1% triton-X 
100, 1% normal goat serum (NGS) in PBS for one hour.  Primary antibody was prepared 
in 0.1% Triton-X 100, 1% NGS in PBS and samples were incubated at 4°C for 16-24 
hours.  After two 30 minute washes in 0.1% TX-100, 1% NGS, PBS, samples were 
incubated in fluorescence-conjugated secondary antibody for 2-4 hours at room 
temperature or 4°C for 16-24 hour. Nuclear staining was done with DAPI. This step was 
followed by two 30-minute rinses in PBS and immersion in Citifluor mounting medium 
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(University of  London).  The tissues were mounted under a coverslip that was elevated 
by flanking coverslips to minimize compression.  Cultured Drosophila cells were stained 
by the same method except that incubations were for two hours in primary antibody at 
room temperature and one hour in secondary antibody at room temperature.  Images were 
captured using a Nikon C1 confocal microscope system and processed using Adobe 
Photoshop software (Adobe). 
 
Cell culture and protein expression. Drosophila S2 cells (from Drosophila 
Genome Resource Center - Bloomington, IN) were maintained in Schneider’s Drosophila 
medium (Lonza, Walkersville, MD, cat. No: Q4-351Q)) supplemented with 13% fetal 
bovine serum (Atlanta Biologicals, Lawrenceville, GA; cat. No: S11550), 0.1% human 
insulin (Sigma; cat. No: I9278)) and penicillin/streptomycin solution at 50ug/ml 
(Mediatech, Herndon, VA; cat. No: 30-001-CI). Expression in Drosophila S2 cells was 
done through transient transfection using the Cellfectin reagent (Invitrogen, Carlsbad, 
CA). Transfected cells were recovered 48 hours prior to assay. 
 
Western blots. DlRF-GFP and DlWT-GFP were independently transfected into 
Drosophila S2 cells.  Cell lysates and media were collected following 16 hr incubation at 
permissive and restrictive temperatures. Lysis buffer consisted of 50mM Tris, 1% 
IGEPAL CA-630 (Sigma, St. Louis, MO), 150mM NaCl containing the protease 
inhibitors EDTA (5mM), PMSF (2mM), Aprotinin, Leupeptin and Pepstatin (5µg/mL 
each). Proteins were separated on 12% (lysates) and 8% (media) SDS-PAGE and 
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Western blotted using anti-Delta antibodies.  Lysates were probed with 10D5 antibody 
that recognizes intracellular domain of Delta17 allowing visualization of full-length Delta 
(DlFL) and C-terminal fragments of cleaved Delta (DlCTF). Equal protein loading was 
validated by staining with anti-actin antibody (Santa Cruz, cat. No: SC1616). Media 
samples were probed with C594.9B antibody (DSHB, University of Iowa) against 
extracellular Delta domain allowing visualization of soluble cleaved Delta (DlEC).  
 
Antibody uptake assay. Drosophila S2 cells transfected with DlRF-GFP and 
DlWT-GFP were heat-pulsed for 16 hours and then incubated for 15 minutes with 
C594.9B (9B) antibody to the extracellular domain of Delta.  Cells were then fixed, 
permeabilized and stained with a secondary antibody to visualize uptake of 9B . Nuclear 




DlRF protein fails to reach neurites and accumulates in the soma of neurons. 
We recently documented that Delta is expressed in all neuroblasts and ganglion mother 
cells as well as in 7 (out of 24) post-mitotic neuronal lineages of the larval thoracic 
ganglion.11  Utilizing the highly polarized neuron cell type we examined the distribution 
of DlRF protein both at permissive (18°C) and restrictive temperatures (30°C) in-vivo.  
Endogenous wild-type Delta (DlWT) is expressed along the full length of neurites and 
their terminals and in vesicles in the cell soma at both temperatures (Fig. 3-1B, 3-1D and 
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see ref. 11). At permissive temperature, the overall pattern of DlRF protein expression is 
similar to that of DlWT (Fig 3-1C).  However, there is accumulation of DlRF in cell somas 
with concomitant decrease of expression in neurites (Fig. 3-1C). At the restrictive 
temperature, DlRF protein is no longer detectable on neurites (neurites are present as 
detected by neuroglian expression, data not shown) and accumulates exclusively in the 
soma (Fig. 3-1E).  While the pattern of DlRF seen in the soma is suggestive of cell surface 
accumulation (Fig. 3-1E, inset), there is little cytoplasm in the neuroblasts, ganglion 
mother cells and neurons and it is difficult to distinguish cell surface expression from 
cytosolic localization.  
 
DlRF protein has diminished cell surface expression in-vitro.  To further investigate the 
trafficking properties of the DlRF protein, we sequenced and cloned the cDNA and 
analyzed its expression in Drosophila S2 cells.  The DlRF allele was found to have two 
mutations in the extracellular epidermal growth factor-like (EGF) repeats, EGF3 
(Gly305->Glu) and EGF4 (Cys348->Tyr).  This result is in accord with the sequence 
reported recently by Parks et.al.12  The C348Y mutation is likely to cause misfolding of 
the EGF4 repeat since it disrupts one of the three disulfide bridges required to maintain 
the canonical EGF fold.  The DlRF coding sequence was cloned into pIZ/V5-His vector 
(Invitrogen) with a GFP tag at the C-terminus. Wild-type Delta (DlWT) was cloned into 
pIZ/V5-His vector with a GFP or a monomeric red fluorescent protein (RFP) tag13 at the 
C-terminus.  Comparison of cellular localization of DlWT with or without fluorescent tags 
by immunocytochemistry reveals that these tags do not affect trafficking properties of 
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Delta (data not shown). Co-transfection of DlRF-GFP and DlWT-RFP in Drosophila S2 
cells shows that in live cells at the permissive temperature, DlRF-GFP has a minor 
presence on the cell surface and is mostly accumulated in large cytosolic vesicles 
localized near the nucleus (Fig. 3-2B,C). At the restrictive temperature (30ºC), DlRF is no 
longer detectable on the cell surface and is found exclusively in large vesicles (Fig. 3-
2E,F).  The perinuclear distribution of DlRF-GFP is seen in conjunction with staining for 
nuclear pore complex proteins (Fig. 3-2H).  In contrast, DlWT-GFP is seen to localize to 
the cell surface and in numerous smaller vesicles at both 18ºC and 30ºC (Fig. 3-2A,D).  
The cell surface DlWT-GFP distribution relative to the nuclear envelope can be seen in 
Fig. 3-2G.  Together, these data demonstrate the aberrant trafficking of DlRF that is 
enhanced at the restrictive temperature.  
To further determine if DlRF fails to reach the cell surface we employed an 
antibody uptake assay on live S2 cells expressing either DlRF-GFP or DlWT–GFP, similar 
to that previously reported14.  We see that the 9B antibody, which is specific for a Delta 
extracellular domain epitope, is rapidly taken up by DlWT-GFP expressing cells and 
shows a complete co-localization on the cell surface and in a number of endocytotic 
vesicles (Fig. 3-3A-C).  In contrast, 9B uptake and surface labeling in is not detectable in 
DlRF-expressing cells (Fig. 3-3D-F).  Only in rare instances weak 9B accumulation is 
detectable on the cell surface of DlRF-GFP positive cells (data not shown).  However, co-
localization of 9B and DlRF in vesicles was never detected.  Altogether, the results of 9B 
uptake assay support the model of a general failure of DlRF to reach the cell surface.  
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Reduced DlRF proteolytic processing is consistent with a failure to reach the cell 
surface. 
In the normal course of its expression the Delta protein is cleaved by the Kuzbanian 
ADAM protease to yield cell-associated C-terminal fragments (DlCTF) and an 
extracellular DlEC fragment which can be found in the culture media (Fig. 3-4, lanes 
1,2,5,6,  and see ref. 15).  While the functional significance of Delta proteolysis is not 
fully resolved,16,12  the cleavage of Delta occurs either in exocytotic vesicles or at the cell 
surface17.  Therefore, if trafficking of Delta to cell surface is compromised, a decrease of 
cleaved Delta released to the media is expected.  With DlRF a decrease of DlEC in the 
media is observed relative to DlWT (Fig. 3-4, lanes 3,4,7,8, lower panel).  This 
corresponds with an overall decrease in DlRF cleavage as seen by reduced levels of DlCTF 
fragments (Fig 3-4, lanes 3,4,7,8, upper panel) as compared to DlWT.  These data support 
the notion that the DlRF protein is trafficked improperly to a compartment where 
proteolysis cannot occur and soluble products cannot be released to the extracellular 
milieu.   
 
3.5: Conclusions 
Our data demonstrate that, at the restrictive temperature, the DlRF protein is 
retained in the perinuclear region and large vesicular bodies, and fails to be expressed at 
the cell surface.  This contradicts an earlier characterization of this, and other, 
temperature sensitive Delta alleles, where loss of function was attributed to an unusual 
property of being retained at the cell surface and failing to undergo endocytosis.6,7  In 
 89
these previous studies localization of the DlRF and the DlCE9 protein at the cell surface 
was interpreted from brightfield views of peroxidase immunohistochemical stained 
tissue, which were limited in resolution.6,7  Transmission electron microscopy images of 
cone cells demonstrate DlRF protein at the “cell periphery” without reference to 
significant landmarks such as the nucleus.6  If DlRF were deficient in endocytosis we 
would predict that its localization in thoracic ganglion neurites and their terminals would 
persist, and likely intensify, at restrictive temperatures.  In fact, the opposite is seen, with 
neurites being devoid of DlRF at the restrictive temperature, indicating DlRF fails to traffic 
to the neurites.  This inability of DlRF to traffic to the cell surface is supported by our in-
vitro data.  We therefore conclude that the loss-of-function properties of DlRF are due to 
its inability to complex with Notch due to its restricted intracellular location.  At the 
permissive temperature, however, the small fraction of DlRF that reaches the cell surface 
is likely sufficient for Notch signaling in-vivo. These findings do not undermine or 
address models whereby ubuiqitin-dependent endocytosis and/or epsin-dependent 
recycling of Delta is a required step for Notch activation.9,10  Rather, these finding 
contribute to such investigations by demonstrating that the DlRF allele has limited utility 
for the explicit study of Delta endocytosis mechanisms, yet remains a well-suited tool for 
loss-of-function studies.  
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Figure 3-1. DlRF protein fails to traffic to neurites and accumulates in the soma of neurons. 
 
Whole mount Drosophila 3rd instar larval brains were fixed in 2% paraformaldehyde, stained with anti-
Delta antibody (10D517) and imaged with Nikon C1 confocal microscope.  All images show ventral views.  
Cell soma of neuroblasts and neurons (filled arrows) and associated neurite bundles (arrowheads) are 
denoted.  (See 11 for details).  (A) Schematic illustrating confocal plane of imaging in the thoracic ganglion. 
(B, D) Wild type Canton S thoracic ganglia at indicated temperatures.  (C, E) DlRF thoracic ganglia at 
indicated temperatures.  Insets are magnified images of the cell soma of neurons, ganglion mother cells and 





















Figure 3-2. DlRF protein has diminished cell surface expression. 
 
Drosophila S2 cells were co-transfected with DlRF-GFP and DlWT-RFP and live-imaged with Nikon C1 
confocal microscope. (A-C) Cells at permissive temperature (18ºC). (D-F) Cells after 16 hrs at restrictive 
temperature (30ºC).  Insets represent overexposed versions of the same images to highlight surface 
localization.  S2 cells were independently transfected with DlWT-GFP (G) and DlRF-GFP (H), fixed and 
stained with MAb414 antibody (Covance, cat. No: MMS-120R) that recognizes nuclear pore complex 
proteins. DlRF protein accumulates in the perinuclear region, whereas DlWT is at the cell surface and in 






















Figure 3-3. DlRF protein fails to traffic to the cell surface. 
 
Drosophila S2 cells transfected with DlRF-GFP and DlWT-GFP were heat-pulsed for 16 hours and then 
incubated for 15 minutes with C594.9B (9B) antibody to the extracellular domain of Delta.  Cells were then 
fixed, permeabilized and stained with a secondary antibody to visualize uptake of 9B . Nuclear staining was 
done with DAPI.  (A-C) 9B antibody and DlWT-GFP co-localize in several vesicles (arrowheads) and at the 
cell surface. (D-F) In contrast, DlRF-GFP fails to uptake 9B, with most of the protein accumulated in the 






















Figure 3-4. Western Blot analysis of Delta proteolysis. 
 
DlRF-GFP and DlWT-GFP were independently transfected into Drosophila S2 cells.  Cell lysates and media 
were collected following 16 hr incubation at permissive and restrictive temperatures.  Proteins were 
separated on SDS-PAGE and Western blotted using anti-Delta antibodies.  Lysates (top panel) were probed 
with 10D5 antibody that recognizes intracellular domain of Delta17 allowing visualization of full-length 
Delta (DlFL) and C-terminal fragments of cleaved Delta (DlCTF). Equal protein loading was validated by 
staining with anti-actin antibody (Santa Cruz, cat. No: SC1616). Media samples (bottom panel) were 
probed with C594.9B antibody (DSHB, University of Iowa) against extracellular Delta domain allowing 
visualization of soluble cleaved Delta (DlEC). Results from two experimental replicates are shown. Note the 
larger size of DlFL and DlCTF relative to native Delta is due to the GFP fusion.  
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CHAPTER 4:  
KUZ AND TACE CAN ACTIVATE NOTCH INDEPENDENT OF LIGAND. 
 
 
Material from this chapter has been published in the following form: 
Delwig, A. and Rand, M.D. (2008). Kuz and TACE can activate Notch independent of 
ligand. Cellular and Molecular Life Sciences. In press. 
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4.1: Abstract  
A central mechanism in activation of the Notch signaling pathway is cleavage of 
the Notch receptor by ADAM metalloproteases. ADAMs also cleave Delta, the ligand for 
Notch, thereby downregulating Notch signals.  Two ADAMs, Kuzbanian (Kuz) and 
TNF-α converting enzyme (TACE), are known to process both Delta and Notch, yet the 
role of these cleavages in signal propagation has remained controversial. Using an in-
vitro model, we show that Kuz regulates Notch signaling primarily by activating the 
receptor and has little overall effect on signaling via disabling Delta. We confirm that 
Kuz-dependent activation of Notch requires stimulation of Notch by Delta. However, 
over-expression of Kuz gives ligand-independent Notch activation.  In contrast, TACE, 
which is elevated in expression in developing Drosophila nervous system, can efficiently 
activate Notch in a ligand-independent manner. Altogether, these data demonstrate the 
potential for Kuz and TACE to participate in context- and mechanism-specific modes of 




Notch signaling is a conserved mechanism of cell-cell signaling that is critical for 
specifying cell fates during development (reviewed in [1,2]).  The fundamental role of 
Notch signaling has directed considerable attention to mechanisms that activate the Notch 
receptor.  Core components that initiate Notch signaling are the Delta ligand and the 
Notch receptor, both being single-pass transmembrane proteins.  Additional components 
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include an ADAM (a disintegrin and metalloprotease) protease and a γ-secretase complex. 
The current model of activation holds that engagement of the Notch receptor by Delta 
ligand binding provokes two sequential cleavages of Notch [3-5]. The first rate-limiting 
cleavage, which requires an ADAM protease, is followed by a constitutive 
intramembranous γ-secretase cleavage involving Presenilin [6,7]. The resulting 
intracellular Notch product (NICD) translocates to the nucleus and activates transcription 
of genes of the Enhancer of Split locus (E(Spl)) [8].  This locus encodes seven basic helix-
loop-helix (bHLH) proteins (Mδ, Mβ, Mγ, M3, M5, M7, and M8) that in turn act as 
transcriptional repressors for a number of genes that regulate cell fate decisions [8,9].  
Several aspects of this model remain unresolved.  For instance, there is 
contradictory evidence for the role of specific ADAM proteases in propagating Notch 
signals. Genetic analyses in Drosophila, mice and C.elegans strongly implicate 
Kuzbanian (Kuz, a mammalian ADAM10 homolog and one of five Drosophila ADAMs) 
as the ADAM required for Notch activation [10-13]. In Drosophila S2 cells, Kuz and 
Notch can physically associate and Kuz is able to cleave a Notch construct that is lacking 
parts of the extracellular and intracellular domains [14]. Yet, the relationship between 
Notch cleavage and Kuz activity with respect to activation of E(Spl) targets remains 
unresolved. Delta also undergoes Kuz-dependent cleavage [15-17] that inactivates its 
ligand activity and leads to downregulation of Notch signaling [18].  However, the 
relative contribution of Kuz to Notch activation versus Delta inactivation remains 
unclear. Experimental data is contradictory on the role of TNF-α converting enzyme 
(TACE, a mammalian ADAM17 homolog) in Notch activation. Biochemical studies show 
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that in mammalian cells TACE and not Kuz is required for cleavage of various Notch1 
constructs that are missing extracellular domain [7,19]. In Drosophila S2 cells, 
overexpressed TACE can noticeably compensate for the loss of Kuz-dependent cleavage of 
Notch [14]. This fact is in contradiction with the phenotypic data from TACE null mice 
that do not exhibit neurogenic phenotypes akin with Notch mutations [20] whereas Kuz 
null mice do [21]. Thus, it is still not clear whether TACE-dependent cleavage of Notch 
leads to its activation.  Furthermore, the potential for ADAMs to act in a ligand-
independent manner has not been thoroughly characterized.   
To investigate the explicit activity of ADAMs in signal sending versus signal 
receiving cells, we developed an in-vitro model using neuronally-derived Drosophila 
ML-DmBG2-c6 cells that utilize endogenous Notch and Kuz expressed at relevant 
physiological levels. We demonstrate that Kuz acts primarily in signal receiving cells and 
is required for Notch-dependent activation of E(Spl) targets.  Kuz activity toward 
regulating Delta function is small by comparison.  Overexpression of Kuz can activate 
Notch independent of Delta stimulation.  In contrast to Kuz, we find that TACE at near-
physiological expression levels is highly effective at activating Notch in a ligand-
independent manner.  We find an example of differential levels of TACE expression in 
developing Drosophila tissues, pointing to specific contexts where these ADAMs may 
act.  Altogether, these data clarify a more explicit role for ADAMs in regulating Notch 
signals predominantly through the signal receiving cells and demonstrate the potential for 
Kuz and TACE to act on Notch in a ligand-independent manner.  
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4.3: Materials and methods 
Cell culture. All cells are from Drosophila melanogaster and available at the 
Drosophila Genome Resource Center (Bloomington, IN). Cells were routinely 
maintained in Schneider’s Drosophila medium (Lonza, Walkersville, MD, cat. No: Q4-
351Q)) supplemented with 13% fetal bovine serum (Atlanta Biologicals, Lawrenceville, 
GA; cat. No: S11550), 0.1% human insulin (Sigma; cat. No: I9278)) and 
penicillin/streptomycin solution at 50ug/ml (Mediatech, Herndon, VA; cat. No: 30-001-
CI).  The S2 cell line was originally derived from Oregon R embryos on the verge of 
hatching [22]. The S2-Mt-Dl (DlS2) cell line was made from S2 cells stably transfected 
to express wild-type Delta from a copper-inducible metallothionein promoter [23]. ML-
DmBG2-c6 (C6) cell line was made from brain and ventral ganglion of late 3rd instar 
larvae [24]. These cells were originally characterized as being immunoreactive to HRP (a 
neuronal marker in insects), and having detectable levels of acetylcholine, L-DOPA, 
substance P, proctolin, and somatostatin, and no detectable GABA [24-26].  We observe 
that knockdown of Kuz or Notch expression does not effect proliferation rate or cell 
morphology of C6 cells.  C6Kuz and C6TACE cell lines were made by stable transfection of 
C6 cells with pIZ Kuz and pIZ TACE plasmids respectively according to the 
manufacturer’s protocol for making a polyclonal cell line (Invitrogen, document. No 25-
0283). pIZ Kuz with V5 tag at the 3’ end was made by cloning Drosophila Kuz cDNA 
(gift from Spyros Artavanis-Tsakonas, Harvard Medical School [15]) into pIZ/V5-His 
vector (Invitrogen, Cat. No V8010-01). The pIZ TACE construct was made by cloning 
Drosophila TACE cDNA with an HA tag at the 3’-end from the pUAST-TACE plasmid 
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(gift from Ben Shilo, [16]) into pIZ/V5-His vector (Invitrogen, Cat. No V8010-01) using 
EcoRI and XbaI restriction enzymes and verified by direct DNA sequencing. The 
expression of Kuz-V5 in C6Kuz cells and TACE-HA in C6TACE cells were validated by 
immunostaining and Western blotting. For both TACE and Kuz, we observe bands on 
Western blots indicative of approximately 50% of the total protein in the latent pro-
enzyme form, with the remainder in the active form.. 
For transient transfections, cells were plated in a 12-well plate and allowed to 
adhere until 60-70% confluent. Medium was then aspirated and replaced with a 
transfection mix consisting of 1 µg plasmid DNA and 5 µl Cellfectin (Invitrogen, Cat. 
No: 10362-010) in 150 µl serum free Schneider’s Drosophila insect media.  Transfection 
mix was applied for four hours under rocking motion followed by recovery in complete 
medium for 16-24 hours prior to assays. 
 
RNA interference (RNAi). Double-stranded interference RNA treatment of 
Drosophila cells was done essentially as described [27]. Approximately 500 bp PCR 
products from the 5’ coding region of target genes were amplified with following primers 
that incorporated 5’ flanking T7 sequence (5’-GAA TTA ATA CGA CTC ACT ATA 
GGG AGA-3’): Kuz (5’-ATG TCA TCA AAA TGT GCT TTC AAC-3’, 5’-GTG ACT 
GTT GTT GCT GAG GAT G-3’), TACE (5’-GGA CGA TGT GGT GCA CAG G-3’, 5’-
GTG CAG CTC ATT GTC CAG AG-3’), Delta (5'-CAC AGT CAT CGT GCA GGT 
TC-3', 5'-CAG CGA CGT GTA CTG CGA TTC -3'), Notch (5'-ATG CAA TCG CAG 
CGC AGC C-3', 5'-GCT GAC AGG TGC CTC CAT TG-3'). These products were used 
 102
as a template for in-vitro RNA synthesis using the MEGAscript T7 kit (Ambion, Cat. No 
1334). Double stranded RNA was added to cells at concentrations of 40µg per 100mm 
culture dish and incubated for 3 days. RNAi-treated cells were then used in subsequent 
assays. 
 
In-vitro assay of Notch activation. Signal sending cells (Delta positive, DlS2; and 
control S2 cells that don’t express Delta) were plated into 6 well plates and allowed to 
adhere until 100% confluent.  Media was aspirated and cells were washed once in Robbs 
PBS [28]. Cells were then fixed in 5% formalin (made in Robbs PBS) for 10 min. at 
room temperature to cross-link polynucleotides and proteins.  After two additional 
washes in Robbs PBS, 15x107 signal receiving cells (Notch positive, C6) were added per 
well for 1 hr 30 min to induce Notch signaling. Following this induction, cells were 
processed for RNA extraction and cDNA synthesis as described below. All assays except 
for the dose-response experiment (Fig. 4-2F) relied on the basal expression of Delta in 
DlS2 cells, and did not require use of CuSO4 induction of Delta expression. For the dose-
response assay, protein expression in DlS2 cells was induced with 50 µM and 350 µM 
CuSO4 addition to the medium for 16 h prior to assay. No CuSO4 was added to DlS2 cells 
that were treated with Delta RNAi. All experiments were done in a minimum of 
triplicates.  
 
In-vivo analysis of gene expression. Brains (abdominal ganglia, thoracic ganglia 
and optic lobes only) and wing disks (with haltere disks) of wandering 3rd instar larvae 
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from wild-type Drosophila melanogaster (Canton S strain) were dissected in a drop of 
Robbs PBS on silicone plates (Sylgard® 184 silicone elastomere kit, Dow Corning, 
Midland, MI) under Nikon SMZ1000 dissecting microscope and transferred directly into 
1.5ml microfuge tubes filled with 100µl of Trizol (Invitrogen, Cat. No. 15596-026).  10 
brains or wing disks were collected per experiment.  Collected tissue was homogenized 
(Kontes Pellet Pestle® cordless homogenizer) and processed for RNA extraction and 
cDNA synthesis as described below. 
 
RNA extraction and cDNA synthesis.  Cells and larval tissues were lysed in 1 ml 
Trizol (Invitrogen, Cat. No. 15596-026). RNA extraction was performed according to the 
manufacturer’s protocol (Invitrogen, Cat. No. 15596-026).  Briefly, RNA was separated 
into aqueous phase by addition of 200 µl chloroform followed by vigorous mixing and 
centrifugation at +4°C in a microfuge at 16,100g for 15 min. 400 µl of aqueous phase 
were transferred to a new 1.5 ml Eppendorf tube and RNA was precipitated by addition 
of 500 µl 100% isopropanol followed by 10 min. incubation at room temperature and 
centrifugation at +4°C at 16,100g for 15 min. The resulting RNA pellet was washed in 
75% ethanol and dissolved in DEPC-treated water at +55°C for 10 min. Concentration of 
RNA was measured using Nanodrop® ND-100 spectrophotometer (NanoDrop, 
Wilmington, DE). 10 µg of RNA from cell lysates were treated with Turbo DNA-free Kit 
(Ambion, Cat. No AM1907) to remove any contaminating DNA. DNAse treatment was 
omitted for lysates from Drosophila tissues (due to low RNA yield).  cDNA was 
generated using 800 ng of RNA with oligo(dT) in the SuperScript First-Strand Synthesis 
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System for RT-PCR (Invitrogen, Cat. No 11904, 18080). Samples that were not treated 
with DNAse were processed in duplicates that included no RT control. In all cases, the 
contribution of genomic DNA to the PCR signal was less than 1%. 
 
Quantitative analysis of gene expression. Levels of gene expression were 
determined by real-time, quantitative polymerase chain reaction (qPCR) analysis using 
SYBR® Green dye (Sigma, Cat. No S5193) and an ABI PRISM 7500 Fast Sequence 
Detection System. Expression of target genes was normalized to the expression of RP49 
gene. We observed that levels of RP49 expression were stable and comparable across 
various cell lines and Drosophila tissues.  Expression values were determined using 
either the comparative ∆∆CT method [29] or straight ∆CT values. Analysis was done in 
ABI 7500 Fast System SDS software (version 1.3.1) and Microsoft Excel (Office 2003). 
Statistical significance of the difference in expression was determined by running a 
Student’s t-test in Microsoft Excel (Office 2003). PCR primers were manually designed 
to amplify 200-300 bp fragments at the 3’ end of the coding region: Kuz (5’-GAA TTT 
GTT GCT CAA CCG GAA G-3’, 5’-CTC CGC CGC GTG AAT AAT G-3’), TACE (5’-
CAT CAC AGG ATT CTG CAA CAA G-3’, 5’-GAA TCA CTC GAC GCC TCT C-3’), 
Delta (5’-CAT ATG CGG AGT GCC GCA G-3’, 5’-GGC GAG GGT TCC TAC TGT 
AG-3’), Notch (5’-GAA TCT GCC CAG TCC GTAC-3’, 5’-CCA TTC ATC CCG AGT 
CCT-3’), Mβ (5’-CTA CGT TCA TGC TGC CAA TG-3’, 5’-ATT CAG AGG GTG 
GTG GAG TG-3’), Mγ (5’-GTC AAT GAG GTC TCC CGT TC-3’, 5’-GGT CAA CAG 
GGA ATG ACT GG-3’), rp49 (5’-AGT ATC TGA TGC CCA ACA TCG-3’, 5’-TTC 
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CGA CCA GGT TAC AAG AAC-3’). Primers were validated by template dilution 
standard curve analysis, identification of single PCR products on agarose gel and direct 
DNA sequencing. The contribution of genomic DNA to the PCR signal was determined 
by analyzing samples omitting the RT step.  
 
Western blot analysis.  Cells were lysed for 10 minutes on ice with 50 mM Tris, 
1% IGEPAL CA-630 (Sigma, St. Louis, MO), and 150 mM NaCl, containing the 
protease inhibitors 5 mM EDTA, 1 mM PMSF, and 5 µg/mL each of aprotinin, leupeptin, 
and pepstatin. SDS-PAGE sample buffer containing β-mercaptoethanol was added to cell 
lysates and samples were boiled for 5 minutes. Proteins were separated on SDS-PAGE 
(12% for Delta and 6% for Notch) and transferred to PVDF membranes (Millipore 
Corporation, Danvers, MA) for quantitative Western blot analysis using an Odyssey 
infrared imager (Li-Cor, Lincoln, NE).  The BCA assay (Pierce, Rockford Il.) was used 
to determine protein content in samples and to ensure equal loading of protein on a gel.  
Primary antibodies were specific for Drosophila proteins and included: rat monoclonal 
10D5 anti-Delta intracellular domain [30] and mouse monoclonal C17.9C6 anti-Notch 
intracellular domain (gift from Spyros Artavanis-Tsakonas, Harvard Medical School). 
Secondary antibodies included: goat anti-rat IRDye700 (Rockland, Gilbertsville, PA) and 
goat anti-mouse Alexa680 (Molecular Probes, Cat. No: A-21057).  All antibodies were 
used at 1:5,000 dilution.  Protein bands were quantified using Odyssey software (version 




Immunostaining.  Cell surface staining of Delta was done in non-permeabilized 
cells. Briefly, DlS2 cells were fixed in 2% paraformaldehyde in Robb’s PBS [28] for 10 
minutes, washed twice in Robbs PBS, and then blocked with 1% normal goat serum 
(NGS) in Robbs PBS for one hour.  C594.9B (9B) antibody (DSHB, University of Iowa), 
specific  for extracellular domain of Drosophila Delta, was prepared in 1% NGS Robbs 
PBS at 1:5000 dilution and samples were incubated at room temperature for 1 hour.  
After two washes in Robbs PBS, samples were incubated with anti-mouse Alexa488 
secondary antibody (Molecular Probes, Cat. No: A-11029) for 1 hour at room 
temperature. After additional wash in Robbs PBS, cells were immersed in Citifluor 
mounting medium (University of London) and mounted on a coverslip.  Images were 
captured using a Nikon C1 confocal microscope system and processed using Adobe 
Photoshop software (Adobe). 
 
4.4: Results 
Development of a robust in-vitro assay of Notch activation. To investigate the 
contribution of Kuz and TACE to Notch activation and Delta inactivation, we developed 
an in-vitro assay where signal sending cells that selectively express Delta are co-cultured 
with signal receiving cells that selectively express Notch (Fig. 4-1A).  In designing this 
assay we sought to use endogenous Notch that is expressed at relevant physiological 
levels.  Since one of the long-term goals in our laboratory is to understand the role and 
regulation of Notch signaling during development of Drosophila larval nervous system, 
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we sought to carry out in-vitro experiments in cells that mimic this context.  ML-
DmBG2-c6 (C6) cells derived from larval nervous system [24] are particularly well 
suited for the role of signal receiving cells due to the fact these cells express Notch and 
no detectable Delta as determined by Western blotting (Fig. 4-1B and [31]). 
Comparatively, Notch expression is somewhat lower than the average level seen in the 
larval brain (approximately 25%, Fig. 4-1D), yet, the expression level of Kuz is similar to 
that found in the larval brain (Fig. 4-1D).  In contrast, the expression level of TACE in 
C6 cells is less than 5% of that seen in larval brains (Fig. 4-1D).  We found this 
expression profile an optimal attribute for selective analysis of Kuz in the absence of 
TACE in initial experiments (see below).   
For signal sending cells we were unable to identify a neuronally derived cell line 
that selectively expresses Delta, and instead used the well-characterized Delta-S2 (DlS2) 
stable transformant line [23].  Of technical importance, we found that DlS2 and its parent 
cell line, S2 cells, express significant levels of Mβ and Mγ (Fig. 4-1E), which is a spurious 
observation since these cell lines fail to express Notch [32]. In order to overcome the 
contribution of Mβ and Mγ mRNA from these cells to the signal-receiving C6 cells we 
introduced a brief formalin fixation step to DlS2 and S2 cells prior to presentation to C6 
cells.  This fixation procedure is a modified version of the one reported previously [18]. We 
found that formalin fixation effectively abolishes the ability to detect Mβ and Mγ mRNA 
extracted from these cells by our qPCR methods (Fig. 4-1E) presumably due to 
crosslinking of protein-RNA complexes that is subsequently removed during phenol-
chloroform extraction.  Formalin treatment does not grossly alter the level of full-length 
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mature Delta in DlS2 cells (Fig. 4-1F). However, a small fraction of high molecular 
species that is immunoreactive with Delta antibody is present (marked by asterisk in Fig. 
4-1F) indicative of cross-linking of Delta either to itself or to other proteins. In addition, 
with formalin treatment we see less C-terminal derived cleavage product (DlCTF, Fig. 4-
1F) which likely reflects a decreased immunoreactivity of these fixed fragments to anti-
Delta antibody. 
 Stimulation of Notch in C6 cells with Delta on DlS2 cells leads to a dramatic 
increase in Notch activation as measured by the expression level of E(Spl) mRNA (Fig. 
4-1C). Time-course analysis of Delta-induced Notch activation revealed that E(Spl) 
expression increases within 30 minutes after Notch expressing cells make contact with 
Delta expressing cells and reaches maximum level at 90 min (Fig. 4-1G). We therefore 
used 90 min stimulation for all subsequent assays.  While two representative E(Spl) 
genes, Mβ and Mγ, were used in this study, both of these Notch targets showed similar 
responses in all experiments, therefore only Mβ results are shown.  The wide dynamic 
range of Delta-induced Notch activation presented optimal conditions for the analysis of 
the contribution of Kuz (and other elements of the Notch pathway) to the regulation of 
Notch signaling. 
To confirm that activation of E(Spl) genes in this assay is Notch specific, we 
downregulated expression of Notch using RNA interference (RNAi) [27] (Fig. 4-
2A,C,D).  Knockdown of Notch expression (Fig. 4-2C) led to complete unresponsiveness 
to Delta stimulation as seen by a lack of induction of Mβ expression (Fig. 4-2B).  We 
noted that RNAi mediated knockdown of Notch expression led to a 70% reduction in 
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mRNA (Fig. 4-2C), a 90% reduction in protein (Fig. 4-2D) and 100% reduction in 
activity (Fig. 4-2B) confirming that RNAi is very effective at removing the activity of 
target proteins in this cell line. Based on this robust reduction of Notch gene products 
with RNAi, in subsequent experiments where we could not test the level of protein due to 
unavailable immunoreagents, we assumed that removal of >70% of target mRNA 
corresponds with an equal or greater reduction in the associated protein. To confirm that 
Notch activation was specific to Delta stimulation, we titrated Delta expression in signal 
sending cells (Fig. 4-2E,F). Notch activation showed linear response to the dose of Delta 
ligand (Fig. 4-2G). 
 
Kuz is required for Delta-induced activation of Notch. To investigate the 
requirement for Kuz in signal receiving cells, we downregulated its expression in C6 cells 
with RNAi and analyzed the level of Delta-induced Notch activation (Fig. 4-3A). First, 
we demonstrated that RNAi mediated knockdown of Kuz expression in C6 cells leads to 
more than 80% reduction in Kuz mRNA (Fig. 4-3C) and loss of Kuz-dependent cleavage 
of Delta (Fig. 4-3D and [15,17,30]) showing that Kuz RNAi is effective at 
downregulating both Kuz expression and Kuz activity. This knockdown of Kuz 
expression leads to 90% reduction in Notch activation (Fig. 4-3B) indicating that Notch 
activation is highly sensitive to the presence of Kuz in the same cell.  
In the course of monitoring Kuz expression levels subsequent to Delta stimulation 
we found that Kuz is moderately upregulated in C6 cells after 90 minutes of stimulation 
by Delta (Fig. 4-3H) suggesting a potential positive feedback loop that can amplify 
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Delta/Kuz-mediated Notch signaling. For comparison, Notch activation does not affect 
the expression of itself or another ADAM, TACE (Fig. 4-3H).  To further study the effect 
of Kuz expression levels on Notch activation we created a stably transformed C6 cell line 
C6KUZ (see methods).  In this context where an 8-fold increase in Kuz expression is 
achieved (Fig. 4-3E), a 14-fold increase in Notch activation is seen even in the absence of 
ligand stimulation (Fig. 4-3F). Notch in these cells still responds to Delta stimulation, and 
the final level of Notch activation is similar to that observed with Delta stimulation in the 
parent C6 cell line (Fig. 4-3F). Furthermore, the ligand-independent activation of Notch 
in C6KUZ cells is due to increased Kuz expression since partial knockdown of the 
overexpressed Kuz in these cells leads to a decrease of Mβ expression (Fig. 4-3G). 
Altogether, these results demonstrate that Notch activation is highly responsive to 
Kuz activity on the signal receiving cell.  Whereas ligand engagement is required to 
invoke Notch activity with endogenous levels of Kuz, elevated levels of Kuz are 
sufficient to invoke ligand-independent Notch activation. 
 
Kuz cleavage of Delta has little effect on Notch signaling. Several studies point 
to a role for Kuz cleavage of Delta in regulating Notch signaling [10,15,18,33,34].  
However, this role has remained somewhat unresolved, in part due to attempts to 
interpret outcomes in the complex context of developing tissues [10,13,15]. We therefore 
investigated the contribution of Kuz to regulating Delta ligand activity in our assay 
system where ligand activity can be assayed more directly. First, we found that Notch 
activation responds in a linear manner to the level of Delta protein expression in the 
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signal sending cell (Fig. 4-2G). We next downregulated the Kuz expression in signal 
sending cells (DlS2) and measured the ability of these cells to activate Notch (Fig. 4-
4A,D).  In DlS2 cells, we find approximately 30% of Delta is cleaved at a basal steady 
state. Removal of Kuz in DlS2 cells with RNAi essentially abolishes generation of the P1 
cleavage product (Fig. 4-4B,E also see [17]).  Despite this inhibition of Delta cleavage, 
Kuz RNAi results in a negligible increase in Delta ligand activity (Fig. 4-4C).  However, 
this level of Delta expression results in strong stimulation of Notch. At lower levels of 
Delta expression, achieved with Delta RNAi, Kuz RNAi similarly inhibits Delta cleavage 
(Fig. 4-4E) and gives a mild (approximately 2-fold) increase in Notch signaling (Fig. 4-
4F).  Overall, these results reinforce that Delta is sensitive to Kuz cleavage, however, 
Kuz has comparatively little overall effect on Notch activation via modulation of Delta 
ligand activity. 
 
TACE can activate Notch in ligand-independent manner. The TACE ADAM 
protease has been implicated in the cleavage of Notch [7,14,19], while also showing 
activity in Delta cleavage [16].  However, the contribution of TACE to Notch activation 
remains unclear.  We first noted that TACE mRNA expression is significantly enriched in 
the brain of 3rd instar larvae as compared to the levels in the whole larvae and wing disks 
(Fig. 4-5A), suggesting that TACE has a specific role in nervous system development. 
We therefore asked whether TACE functions in regulation of Notch signaling in our 
Drosophila neuronal-derived cell culture assay. In contrast to the larval brain, C6 cells 
show very little TACE expression (Fig. 4-1D).  We therefore established a stably 
 112
expressing C6TACE cell line (see methods), which resulted in constitutive TACE 
expression at levels 25-fold higher than those observed in larval brain (Fig. 4-5B). At this 
level of TACE expression, we see robust Notch cleavage (Fig. 4-5E) and very strong 
ligand-independent activation of Notch (Fig. 4-5C). Treatment with Notch RNAi 
confirms that TACE-induced Mβ activation is Notch dependent (Fig. 4-5D). 
Furthermore, removal of Kuz with Kuz RNAi from C6TACE cells does not affect 
constitutive Notch activation by TACE (data not shown) indicating that TACE does not 
act indirectly through Kuz, but is likely to act on Notch directly. We next attempted to 
obtain TACE expression levels that approximate a relevant endogenous level. Using 
RNAi we were able to reduce steady state TACE expression in these cells (C6TACE(i)) to 
levels approximating those found in the larval brain (Fig. 4-5B).  We observe a 17-fold 
activation of Notch in C6TACE(i) cells relative to control C6 cells, again indicating a 
constitutive activation of Notch by TACE (Fig. 4-5C).  Overall, these data point to a 
potential role for TACE in ligand-independent activation of Notch at expression levels 
that approximate those seen in the developing larval CNS. 
 
4.5: Discussion 
Our in-vitro assays of Notch activation show that in signal receiving cells where 
Kuz is the predominant ADAM expressed, Notch activation is very sensitive to the level 
of Kuz expression. This study therefore provides molecular evidence to corroborate 
earlier genetic and biochemical studies that suggest that Kuz acts directly on the Notch 
receptor to activate it [10,11,14].  
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We also demonstrate that at basal levels of Kuz expression in C6 cells, which 
approach those observed in the larval brain, Notch responds robustly to Delta ligand 
activity in a Kuz-dependent manner.  As the levels of Kuz decrease, Notch loses 
responsiveness to Delta stimulation. On the other hand, as the Kuz levels exceed relevant 
endogenous levels, Notch becomes activated, albeit moderately, without stimulation by 
Delta.  Unlike Kuz, when TACE is expressed at levels approximating those observed in 
the brain it efficiently activates Notch in a ligand-independent manner.  As TACE 
expression exceeds endogenous levels, its ability to activate Notch becomes even more 
potent.  These results suggest that in the developing larval brain, TACE has the capacity 
to contribute to ligand-independent activation of Notch.  Altogether, the data support a 
mechanism whereby Notch activation and the responsiveness of Notch to Delta are 
intimately linked to the expression levels of Kuz and TACE.  As Notch signaling is a 
ubiquitous pathway used for morphogenesis of a number of tissues, this mechanism is 
likely utilized in specific contexts during development.  Two prominent examples from 
Drosophila are border cell migration in follicle development [35] and cardiogenesis [36] 
where Kuz plays a dominant role. Ligand-independent activation of Notch in these and 
other contexts remains to be investigated.  Nonetheless, our data provide rationale to 
investigate ADAM-initiated ligand-independent Notch activation in development and in 
pathological states.  In support of this notion elevated expression of TACE and Kuz are 
detected in multiple human pathologies [37-39] suggesting that Notch signaling can 
potentially be uncoupled from ligand in these contexts.  Indeed, in pancreatic cancer, 
aberrant expression of a related protease, matrix metalloproteinase-7, was recently 
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reported to instigate Notch signaling possibly by cleaving Notch in a ligand independent 
manner [40].  
In contrast to signal receiving cells where Notch activation is very sensitive to the 
presence of Kuz, removal  of Kuz activity from Delta expressing cells does not greatly 
change their signaling capacity. This is in contrast to the previously suggested role for 
Kuz to affect Delta ligand activity [15,18].  Our conclusion is with the caveat that Delta 
expressing cells in our assay system are necessarily fixed prior to presentation to Notch 
expressing cells. Nonetheless, we have previously reported that Kuz-dependent cleavage 
of Delta happens prior to Delta endocytosis [30] either on the way to the cell surface or 
on the cell surface itself.  The simplest interpretation of our data follows from the 
hypothesis that full-length un-cleaved Delta at the cell surface is the signaling competent 
form of the ligand [18].  In this regard, since only ~30% of Delta is cleaved (this study 
and see [17]), removal of Kuz would yield only an approximately 1.5-fold increase in 
full-length ligand.  Since we demonstrate a linear response of Notch signaling to Delta 
concentration, it follows that a meager increase in signaling is anticipated, and indeed 
observed, with removal of Kuz from the signal sending cell.  One prediction from this 
hypothesis is that as the basal level of Delta processing increases, modulation of Kuz 
activity (and activity of other ADAMs that can cleave Delta) can exert greater regulatory 
function on the ligand signal sending capacity. In this regard, mouse and human 
homologs of Delta show a greater basal level of cleavage in cultured mammalian cells 
(A. D. and MDR, unpublished observation and [41]) which may be the underlying reason 
that ADAM10 shows activity in regulating the Delta ligand in a mouse model [34].  
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Additional insight into Notch signaling comes from our observation that formalin 
fixed DlS2 cells elicit Notch activation. This observation corroborates previous studies 
where Notch activation was achieved by the extracellular domain of Delta immobilized 
on beads [42] or clustered with an antibody [43,44].  Fixation will terminate normal cell 
metabolism, including endocytic trafficking of cell surface proteins.  The fact that “fixed” 
Delta elicits Notch activity is inconsistent with the current paradigm of endocytosis-
dependent Delta ligand activity.  Several lines of evidence indicate endocytic trafficking 
is required for Delta ligand activity (reviewed in [45]).  One model maintains that the 
endocytic uptake of Delta provides the “force” necessary to pull on and dissociate the 
Notch heterodimer, leading to receptor cleavage and activation [46].  While our data 
refute this model, it remains a possibility that endocytosis, or general motility of the 
signal receiving cell may provide the “mechanical” force necessary to induce Notch 
activation when bound to immobilized ligand.  A second model points to a role for 
endocytic recycling of the ligand as a necessary pathway for ligand to become active 
[47,48]. However, with the formalin fixation protocol, our results are unable to lend 
additional insight into this latter model.  
In summary, we demonstrate with a defined in-vitro experimental model of Delta-
Notch signaling that ADAM proteases predominantly act at the level of the receptor.  
Whereas Kuz is necessary for ligand-induced activation of Notch, it is sufficient for 
ligand-independent receptor activation when overexpressed.  By contrast, the related 
ADAM, TACE, is sufficient to induce ligand-independent Notch activation when 
expressed at levels approaching those seen in developing brain tissue.  These data 
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demonstrate the potential for Kuz and TACE to participate in unique modes of Notch 
activation during development.  
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Figure 4-1. In-vitro assay of Notch activation. 
 
(A) Schematic of co-culture assay showing control and experimental wells with signal sending (grey) and 
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Figure 4-1 (continued). In-vitro assay of Notch activation. 
 
full length Delta (DlFL) in signal sending (DlS2) and signal receiving (C6) cells. S2 cells that do not express 
detectable Notch and Delta are used as a control for non-specific stimulation. (C) Fold difference in gene 
expression of two E(Spl) genes, Mβ and Mγ as measured by qPCR (see methods),  in C6 cells following 
co-culture with S2 vs. DlS2 cells. Error bars indicate one standard deviation from the mean. All subsequent 
experiments that show difference in expression are done using qPCR unless otherwise noted. (D) Gene 
expression levels in Drosophila larval brain (L3) and cell lines showing fold difference in expression levels 
of Kuz, TACE and Notch. (E) Mβ gene expression levels in signal sending cells showing the levels before 
and after fixation in 5% formalin. (F) Western blot of cell lysates from non-fixed and formalin-fixed DlS2 
cells stained with Delta specific antibody [30] showing full length Delta (DlFL) and the C-terminal 
fragments of cleaved Delta (DlCTF); the Kuz-dependent P1 fragment and the Kuz-independent P2 fragment 
[17].  Asterisk denotes high molecular weight immunoreactive material indicating possible Delta species 
resulting from cross-linking Delta either to itself or to other proteins. (G) Time course of Delta-induced 
Notch activation in C6 cells (filled squares). Y-axis shows fold change in Mβ gene expression relative to 
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Figure 4-2. Notch activation in C6 cells is Notch and Delta dependent 
 
(A-D) Induction of Mβ expression in C6 cells is Notch dependent. (A) Schematic of the experiment 
showing signal sending cells (grey) and signal receiving (white) cells with and without Notch RNAi (Ni) 
treatments. (B) Delta-induced Mβ expression in C6 cells is greatly reduced after the treatment with Ni. 
Basal level of Mβ expression (C6/S2) is shown for comparison. P-values are with reference to C6/DlS2. 
(C) Average reduction in Notch gene expression following RNAi treatment against Notch in C6 cells. (D) 
Average reduction in Notch protein expression as measured by quantifying band densities on the Western 
blot. Insert shows a sample of the Western blot of cell lysates from C6 cells +/-  RNAi against Notch 
stained with 9C6 antibody against intracellular domain of Notch. Full length Notch protein (NFL).  
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Figure 4-2 (continued). Notch activation in C6 cells is Notch and Delta dependent 
 
(E-G) Notch activation in C6 cells is Delta specific. (E) Western blot showing Delta expression in response 
to CuSO4 induction. S2 cells do not express Delta and serve as a control for non-specific stimulation. Delta 
expression in DlS2 cells is under the control of Cu2+-inducible metallothionein promoter [23]. Since DlS2 
cells express detectable level of Delta in the absence of CuSO4 (lane 3), further titration can be achieved by 
reducing Delta expression in these cells with RNAi against Delta (lane 2). Lanes 4 and 5 show increased 
Delta expression using 50 µM and 350 µM CuSO4. Full length Delta (DlFL). (F) Immunostaining of Delta 
in DlS2 cells corresponding to lanes 2, 3 and 4 in (E) showing increased amount of Delta expression on the 
cell surface. Non-permeabilized DlS2 cells were stained with anti-Delta antibody specific for extracellular 
domain (see methods).  (G) Effect of Delta expression levels in signal sending cells (DlS2) on Notch 
activation in signal receiving cells (C6). Y-axis indicates fold change in Delta-induced Notch activation in 
C6 cells relative to basal level of Notch activation in C6 cells as measured by Mβ gene expression. X-axis 
indicates Delta protein expression in signal sending cells (in arbitrary units (a.u.)) as determined by 
quantification of both full length and cleaved Delta from the Western  blot in (E) (see methods). Numbers 
represent signal sending cells as indicated in (E): 1 – S2; 2 – DlS2 with Delta RNAi; 3 – DlS2; 4 – DlS2 
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Figure 4-3. Notch activation in C6 cells is Kuz dependent. 
 
(A) Schematic of the experiment showing signal sending cells (grey) and signal receiving cells (white) and 
Kuz RNAi (Kuzi) treatments. (B) Average reduction in Delta-induced Notch activation in C6 cells that 
were treated with RNAi against Kuz as measured by Mβ expression. Basal level of Mβ expression is shown 
for comparison (C6/S2). (C)  Average reduction in Kuz expression in C6 cells following treatment with 
RNAi against Kuz. (D) Validation of the effectiveness of Kuz RNAi in C6 cells. Kuz RNAi is effective in 
preventing the Kuz-dependent P1 cleavage of Delta. Western blot of C6 cells transiently transfected with 
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Figure 4-3 (continued). Notch activation in C6 cells is Kuz dependent. 
 
 
(E) Relative levels of Kuz expression in C6 and C6KUZ cell lines. (F) Effect of increase in Kuz expression 
on ligand-dependent and independent Notch activation as measured by Mβ expression. (G) Ligand-
independent activation of Notch in C6KUZ cells is due to increased levels of Kuz expression. Mβ expression 
in C6KUZ cells is reduced following knockdown of Kuz expression. (H) Effect of Notch activation on the 
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Figure 4-4. Kuz has minimal effect on regulating signal sending capacity of Delta. 
 
(A and D) Schematics of the experiments showing signal sending (grey) and signal receiving (white) cells 
and RNAi treatments. (B and E) Western blots showing the effect of Kuz RNAi on Delta cleavage. Asterisk 
in (E) represents overexposed version of the P1 band. (C and F) Effect of decreasing Kuz expression in 
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Figure 4-5. TACE effectively activates Notch in a ligand-independent manner. 
 
(A) Expression of Kuz and TACE in Drosophila 3rd instar (L3) larval brains and wing disks relative to 
whole larvae. (B) TACE expression in C6TACE cells and C6TACE cells treated with TACE RNAi (C6TACE(i)) 
relative to larval brain. (C) Delta-independent Notch activation in C6TACE and C6TACE(i) cells relative to 
basal level of Notch activation in C6 cells. P-values are with reference to C6 cells. (D) TACE-induced 
activation of Mβ expression is Notch specific. Removal of Notch expression with RNAi against Notch in 
C6TACE cells leads to a dramatic drop in the expression of Mβ. (E) TACE promotes Notch cleavage. 
Western blot of cell lysates from C6 and C6TACE cells stained with 9C6 antibody against intracellular 
domain of Notch. Full length Notch (NFL) and C-terminal fragment(s) of cleaved Notch (NCTF).  
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CHAPTER 5:  
SUMMARY AND CONCLUSIONS 
 
The results from our studies of Delta proteolysis support a model whereby Delta 
cleavage serves to downregulated ligand activity as well as relieve in-cis inhibition of 
Notch by Delta. More specifically, we have demonstrated that: (1) Drosophila Delta 
cleavage does not follow the RIP mechanism;(2) Delta cleavage is upregulated upon 
binding to Notch on the same cell; (3) Preventing Delta cleavage leads to an increase in 
ligand activity. 
An important outcome from our results is the lack of support for the model 
whereby Drosophila Delta acts as a receptor and participates in bi-directional signaling 
during Delta-Notch interaction. Our conclusion is reinforced by the results defining the 
cleavage site for the P3 product, which predicts that the cytosolic fragment of Delta is 
likely to remain tethered to the plasma membrane.  This predicted property is consistent 
with our inability to detect endogenous Delta in the nucleus of cells in-vivo. Additional 
data refuting a bidirectional signaling model comes from an unpublished observation 
from our laboratory that overexpressing intracellular fragment of Delta in larval brain, 
eye and wing disks does not lead to any observable phenotypes.  
It remains to be seen if Delta in mammals has any signaling function as a 
receptor. Mammalian Delta and Jagged (a mammalian homolog of Serrate, another ligand 
of Notch) undergo RIP and their intracellular domains localize to the nucleus [1,2]. 
Moreover, intracellular domain of Jagged drives the expression of a reporter gene under 
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AP1 promoter [2]. In addition to mammalian Notch ligands, Xenopus Delta and Serrate 
undergo proteolysis and the intracellular domain of Serrate is localized to the nucleus 
where it is capable of suppressing primary neurogenesis [3].  
Altogether, these results suggest that although the proteolysis of Delta is 
conserved across various phyla, the function of Delta cleavage is likely to have diverged 
during evolution. In Drosophila, Delta acts as a ligand for Notch and the cleavage of 
Delta relieves its ligand function. In vertebrates, this cleavage of Delta and other Notch 
ligands has gained additional signaling function to accommodate more complex contexts 
of cell communication.  
Our study reveals that Delta proteolysis is sensitive to thiol modification. This 
result has fostered a significant new line of inquiry in the laboratory.  Since many 
environmental toxins, including methylmercury and other heavy metals, act through 
adducting cysteines, our findings predict that Delta-Notch signaling is a sensitive target 
for these environmental xenobiotics.  Research into the explicit mechanisms of 
methylmercury perturbation of Notch signaling is currently a major new focus of the 
laboratory. 
The results from our studies of Notch proteolysis and activation support a model 
whereby ADAMs regulate Notch signaling predominantly through the cleavage of the 
receptor.  However, despite the strong effect of TACE on Notch activation in-vitro, 
TACE does not activate Notch in 3rd instar Drosophila larvae (Appendix A) pointing to 
additional mechanisms regulating ADAM-Notch interactions. One hypothesis for the lack 
of TACE-induced Notch activation in-vivo is sorting of TACE-cleaved Notch to 
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endosomes from which Notch cannot signal possibly due to lack of γ-secretase activity that 
prevents further activation of Notch.  This possibility may be in line with a recent study 
reporting that members of NEDD4 family of E3 ubiquitin ligases regulate post-endocytotic 
sorting of Notch to specific endosomes. The choice of endosome determines if Notch is 
allowed to signal or not [4]. Further studies on subcellular localization of TACE-cleaved 
Notch will provide more insight.  
In addition, we identified a novel mechanism whereby Notch activation can be 
achieved independent of Delta via upregulation of Kuzbanian and TACE expression. 
Given that Kuz and TACE expression are elevated in multiple human pathologies, this 
finding provides rationale to investigate the involvement of Notch signaling in such 
contexts. For example, expression of Kuz and TACE is elevated in human breast cancer 
and the presence of Notch expression is correlated with poor prognosis [5]. Our findings 
might provide insight into the mechanism of this correlation by establishing a link 
between the level of ADAM expression and Notch activation thereby offering a novel 
therapeutic target of modulating ADAM activity to control Notch activation.  It is 
interesting to note that human Notch was first identified in a T cell leukemia that resulted 
from a constitutively active form of Notch arising from chromosomal translocation.  By 
analogy, posttranslational means of unregulated activation of Notch, e.g. by misexpressed 
ADAMs might well propagate the cancerous state…. 
Our studies of Delta endocytosis have demonstrated that: (1) Proteolysis of Delta 
happens prior to endocytosis; (2) Cleaved fragments of Delta are segregated into separate 
vesicles in-vivo but not in-vitro; (3) DlRF mutant, reported to be “endocytosis-deficient”, 
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does not reach cell surface; (4) Endocytosis of Delta is not required for Delta signaling 
capacity in-vitro.  Altogether, these results support a model whereby endocytosis of Delta 
serves to modulate overall levels Delta on the cell surface thereby regulating signal 
sending capacity. This mechanism is independent of, and complementary to, Delta 
proteolysis, which we infer from our data is likely to occur on the cell surface. Also, 
these results provide strong evidence against the existing model that endocytosis of Delta 
is required for activation of Notch signaling.  On this note, we see the need to re-examine 
previous studies that provided support for this model.  It may well be that endocytosis is 
not the mechanical force behind Delta activation of Notch, rather endocytosis could be 
required for maintaining the appropriate steady state of surface Delta resulting in an 
appropriate level of Notch signaling… 
Lastly, we obtained confounding and enigmatic in-vivo results namely, that a very 
weak coupling between Notch activation and its immediate targets, the E(Spl) genes, 
exists in 3rd instar Drosophila larvae (Appendix A). At face value, these results highlight 
a higher degree of complexity in the in-vivo context that is not reconstituted in our in-
vitro assays.  It is not hard to invoke additional models whereby one or more Notch-
interacting factors may be present in the larval context that serve to stabilize E(Spl) 
expression once a predetermined steady state of expression is reached.  A cursory 
observation that supports such a mechanism comes from assays we attempted in the 
larval C3 cell line.  In this line, where elevated basal levels of E(Spl) are present, 
activation or inhibition of Notch signaling does not lead to a significant change in E(Spl) 
expression (A.D. and M.R. unpublished observation). However, in the related larval C6 
 133
cell line that expresses low level of E(Spl) at basal level, E(Spl) genes show robust 
response to Notch activation.  Since Notch-like morphologic phenotypes can be observed 
with a lack of perturbation of E(Spl) in-vivo [6], our results also suggest a means whereby 
Notch can relay signals via targets other than E(Spl) during post-embryonic development. 
Overall these results highlight a need for further studies to clarify the link between the 
Notch pathway and E(Spl) genes and identify other targets of activated Notch. This need 
is especially crucial because a majority of studies use E(Spl) expression levels as faithful 
read-outs of Notch activation.  
Future Directions.  The most significant finding in this dissertation is the ability 
of ADAMs to activate Notch in a ligand-independent manner.  This novel mechanism of 
Notch activation can provide a link between the observed upregulation of ADAM 
expression and deregulation of cell fates that is present in several human diseases.  
Further studies on the relationship between ADAMs and Notch activation can offer 
significant insight into pathophysiology of those diseases and offer novel therapeutic 
targets to modulate ADAM activity and Notch activation.  Additionally, the fact that 
Notch signaling is exquisitely sensitive to the level of Kuz and TACE activity provides 
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The first appendix describes our attempts to analyze the effect of TACE on Notch 
signaling during larval development of Drosophila melanogaster.  The results were 
inconclusive and therefore were not prepared for submission as a manuscript.  They 
might of interest to current and future members of the Rand lab as well as members of 
Drosophila research community who study ADAMs and Notch signaling during larval 
development. 
The second appendix is a short report on a series of experiments to determine the 
role of RECK in modulating Kuz activity.  The preliminary nature of this report again 
precluded us from preparing it for submission as a manuscript.  It might be of interest to 




APPENDIX A.  
TACE DOES NOT AFFECT E(SPL) EXPRESSION IN 3RD INSTAR 
DROSOPHILA LARVAE.  E(SPL) SHOWS A LIMITED RESPONSE TO NOTCH 





Our in-vitro findings that TACE is potent Notch activator in C6 cells prompted us 
to examine the role of TACE in-vivo. Expression of TACE is highly enriched in the larval 
brain and downregulated in the wing disk suggesting a potential role of TACE to regulate 
Notch signaling during CNS development.  We manipulated the levels of TACE expression 
in the larval brain as well as wing disks and whole larvae and found that E(Spl) levels are 
not responsive to TACE. We further examined the dependence of E(Spl) on Notch, Delta 
and Kuz and found that E(Spl) genes are only mildly responsive to changes in Notch  
expression in Drosophila larval brain, wing disk and whole larvae.  Additionally, in 
contrast to the suggested role of Notch to regulate cell proliferation and differentiation in 
the larval brain, we could not detect any defects in the CNS associated with the loss of 
Notch signaling. However, we confirmed that Notch signaling is required for proper escape 







Expression profile of Notch pathway in 3rd instar wing disk, brain and whole larvae.  
With the goal of conducting experiments in-vivo, we analyzed the basal expression levels  
of several genes in the Notch pathway as well as ADAM genes in Drosophila larval brain 
and imaginal wing disks (Fig. A-1A).  As we reported earlier, TACE expression is highly 
enriched in the brain and repressed in the wing disk as compared to the whole larvae (Fig. 
A-1A). We found that Mγ expression is also selectively enriched in the brain.  This result 
parallels our in-vitro results which show profound effect of TACE-dependent activation of 
Notch on Mγ expression (see Fig. A-1B) suggesting a causative link between enrichment of 
TACE expression and Mγ activation in the brain.  Therefore, we focused our effort on 
modulating the levels of TACE in the nervous system and monitoring the levels of E(Spl) 
genes with qPCR. 
 
Description of Drosophila strains used to manipulate gene expression in-vivo. To 
modulate the levels of TACE and other components of the Notch pathway in a tissue and 
time specific manner, we chose to use a well established two-partite Gal4-UAS system 
where the expression of a transgene is under the control of a driver that can be spatially or 
temporarily targeted (reviewed in [1]).  
For TACE overexpression studies, we obtained transgenic flies with the  UAS-
TACE construct (tagged with HA at the C-terminus) from the laboratory of Ben Shilo 
(Weizmann Institute of Science, Israel). To validate the UAS-TACE construct, we drove its 
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expression in the whole animal using hs-gal4 driver (Gal4 under the control of a heat-shock 
promoter). Activation of the heat-shock driver results in dramatic upregulation of TACE-
HA gene and protein expression (Fig. A-2A,B) and dramatic increase in Notch cleavage 
(Fig. A-2A) therefore confirming both the effectiveness of inducing TACE expression and 
the catalytic activity of the exogenous TACE-HA construct. Overexpressing the same 
construct in in-vitro in C6 cells shows similar results (Fig. A-2C). Expression of TACEHA 
by hs-gal4 in-vivo results in lethality (summarized in Fig. A-6B-D) mostly at the pupal 
stage. Of technical note, it is difficult to work with UAS- TACEHA strain. Only about 5% 
of progeny of the balanced stock are homozygous for the TACEHA construct making it 
difficult to establish crosses exhibiting the essential markers necessary for analysis at larval 
stages. Also, quite often homozygous UAS-TACEHA flies do not breed well and generally 
die within a few days after eclosion. 
To downregulate TACE expression, we made a transgenic fly carrying a UAS-
TACE RNAi construct that we obtained from the laboratory  of Ben Shilo.  The UAS-
TACE RNAi construct was validated by confirming protein knockdown in cell culture by 
co-transfecting it with an expression vector for TACE in S2 cells (Fig. A-2E).  Ten 
transgenic fly lines were made with the help of the injection services of BestGene Inc. 
(California). We restricted our analysis to five lines that could produce viable homozygotes 
for UAS-TACE RNAi. UAS-TACE line #2 was chosen for further experiments since it 
showed the strongest level of TACE knockdown with heat shock-gal4 induction (Fig. A-
2F). Expression of UAS-TACE RNAi by a number of drivers did not lead to any obvious 
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adult morphogenetic phenotypes (Fig. A-2G and summarized in Fig. A-6) except for the 
behavioral escape response (discussed below). 
Using the analogous methodology we also manipulated expression of Kuz, Delta 
and Notch itself using the following UAS lines obtained from the Drosophila Stock Center 
(Bloomington, Indiana): UAS-Kuz RNAi (summarized in Fig. A-2I-K and Fig. A-6); UAS-
Kuz (Fig. A-2M-O and Fig. A-6); UAS-Notch RNAi (Fig. A-2 P-S and Fig. A-6); UAS-
NICD (Fig. A-2T,U and Fig. A-6); UAS-Delta RNAi (Fig. A-2V-X and Fig. A-6); and 
UAS-Delta (Fig. A-2Y,Z and Fig. A-6). 
 
Characterization of the hs-gal4 driver. In our attempt to modulate TACE levels in the 
CNS, we first used Gal4 driver under the control of the heat-shock promoter. Heatshock-
GAL4 strain of flies (hs-gal4) is a popular tool in the Drosophila research community used 
to activate UAS-linked genes in temporarily restricted manner in all tissues including larval 
brain [2,3]. A typical protocol calls for a single heat pulse of 1 hour at 37°C followed by a 
recovery at 25°C. We further modified this protocol to enhance the potency of GAL4 
induction by substituting a single heat pulse with a train of four pulses at 37°C with one 
hour recovery in between at room temperature. We observe that hs-gal4 induction is 
effective at the level of the whole larvae but is selectively suppressed in the larval brain 
(Fig. A-3A,B). This finding raises concerns about the validity of other studies that relied on 
the hs-gal4 driver to manipulate gene expression in the larval brain [2,3]. Although, it 
should be noted that there are multiple strains with hs-Gal4 driver and authors often do not 
disclose the exact strain used. It might be possible that certain strains of hs-gal4 driver fail 
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to express in CNS due to the positional effect of hs-gal4 transgene insertion in the 
chromosome. The strain of hs-gal4 flies that were used in this study came from the 
Bloomington Drosophila Stock Center. Stock # 1799 (donor: Andrea Brand). We did use 
this strain to drive the expression of UAS constructs in the whole larvae. 
 
TACE does not affect E(Spl) in the larval brain. After failing to drive TACE constructs 
with hs-gal4 driver, we turned to elav-gal4 driver that is known to drive in all neurons and 
produces much higher level of Gal4 expression in the brain (Fig. A-3C). To analyze the 
effect of TACE on Notch activation, we collected all brain tissue and analyzed gene 
expression levels with qPCR. First, we confirmed previous reports that Notch, Delta, Mβ 
and Mγ genes are expressed in proliferative neurons (neuroblasts and ganglion mother 
cells, immediate progeny of neuroblasts, using various lacZ reporter constructs in 
transgenic flies (Fig. A-4A-F). Due to high enrichment of TACE expression in larval CNS 
(Fig. A-1A), we assumed that TACE is present in enough cells to effect Notch signaling. 
For knockdown experiments the spatial expression of endogenous TACE is of concern only 
in RNAi experiments because RNAi only affects endogenous expression.  In 
overexpression experiments, the spatial control of expression is under the control of a 
driver.  
First, we overexpressed TACE to see if we could get additional Notch activation.  
Whereas TACE overexpression in C6 cells leads to a greater than 100-fold increase in 
Notch activation (Fig. A-5A), four-fold overexpression of TACE in larval brain does not 
lead to a change in Notch activation as measured by the expression levels of Mβ and Mγ 
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(Fig. A-5B). There are several possible explanations for the lack of E(Spl) response to 
TACE activity: (1) Notch activation and Mβ and Mγ expression are already at maximum 
level that can not be further increased via cleavage of Notch; (2) TACE does not influence 
Notch activation as measured by E(Spl) expression during larval development. 
We also downregulated TACE expression using newly made UAS-TACE RNAi 
transgenic flies and found no effect on the expression of E(Spl) genes (Fig. A-5B).  Again, 
there are several possible interpretations of these results: (1) expression of endogenous 
TACE does not co-localize with Notch expression in the larval brain (need to do in-situ 
hybridizations for TACE mRNA); (2) RNAi did not lower TACE expression enough to 
elicit an effect. With regard to the latter, we failed to detect any significant change in 
message levels of TACE, and for that matter in Kuz, Delta and Notch, subsequent to RNAi 
knockdown in larval brain in-vivo (Fig. A-3D, A-10C). However, RNAi against Notch, 
Kuz and Delta did produce strong phenotypes in other tissues (such as wing and eye, see 
below), and occasionally a detectable knockdown in protein expression for Notch (Fig. A-
2,6,10) suggesting that even though knockdown at the mRNA level is not detectable, RNAi 
is still effective in decreasing protein levels and protein activity (e.g. receptor function or 
enzymatic activity). It is becoming more common in the Drosophila community for 
researchers to take steps to increase the effect of RNAi by either duplicating a driver, 
duplicating UAS-RNAi construct or adding additional Dicer2 expression (via UAS-dicer2 
line  - available from Vienna RNAi center).  
In summary we see that changes in TACE expression in the larval CNS do not 
effect Notch activation as measured by E(Spl) expression. 
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TACE does not affect E(Spl) in larval wing disks and whole larvae. We also attempted 
to manipulate TACE levels in larval wings disks and whole larvae.  A9-gal4 driver 
expresses in most of imaginal wing disk tissue (Fig. A-4G) that overlaps with the 
expression of Mβ (Fig. A-4H from [4]), Notch and Delta (Fig. A-4J,K from [5]),  and Kuz 
(Fig. A-4I from [6]). Heat-shock-gal4 driver drives in the whole larvae (not verified – 
except for the lack of induction in the CNS). Since wing disk does not express high levels 
of TACE, we hypothesized that overexpressing TACE in this tissue would have a strong 
effect on Notch activation. We find that a 900-fold overexpression of TACE did not lead to 
any significant change in the E(Spl) expression (Mβ, Mγ, M3 and M7 were examined – 
only Mβ is shown in Fig. A-5B). Similarly, a knockdown or a 300-fold overexpression of 
TACE in the whole larvae did not lead to any change in E(Spl) expression (Fig. A-5B).   
Altogether, the results of manipulating TACE expression in larval brain, wing disk 
and whole body show that TACE has no effect on regulating the expression of E(Spl) 
genes. Since we see very strong ability of TACE to activate Notch in-vitro, it suggests that 
additional mechanisms are present in-vivo that regulate TACE interactions with Notch. For 
example, Notch and TACE can be segregated to different cellular compartments or the 
activity of TACE toward Notch is mediated by an adaptor protein. 
 
Manipulation of TACE expression in the giant fiber circuit produces Notch-like 
phenotypes in the escape jump response. After failing to detect any effect of TACE on 
Notch activation as measured by the expression levels of E(Spl), we turned to Notch 
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phenotypes as the readout of Notch activation. Jump response is a robust and stereotyped 
behavior in Drosophila to escape noxious stimuli. When exposed to an odor of propionic 
acid, flies initiate an escape response by jumping and then flying away from the odor. This 
response is mediated by a giant-fiber circuit. A307-gal4 driver expresses in this circuit and 
it has been shown that downregulating Notch expression with A307-gal4 driver using 
Notch RNAi leads to a dramatic decrease in jump responses [7]. We confirm that indeed 
Notch RNAi leads to the dramatic decrease in odor-evoked jumps (Fig. A-6A). 
Overexpression or knockdown of TACE expression in this circuit with A307-gal4 driver 
also led to a strong albeit much lesser reduction in the jump response (Fig. A-6A).  The 
interpretation of these results is complicated by the fact both reduction and addition of 
TACE expression lead to the decrease in jump responses. It is also still unknown what the 
exact role Notch signaling plays in the development or physiology of this circuit. But this is 
the only strong result that we obtained where manipulation of TACE expression leads to a 
Notch-like phenotype. 
Overexpression or knockdown of TACE expression did not lead to any other classic 
Notch phenotypes in the wing and bristles (Fig. A-2G,H and data not shown) with the 
exception of TACE overexpression in eye that does lead to eye malformation (Fig. A-2D) . 
Some caution has to be exercised in interpreting these results due to the little-mentioned 
fact that GMR driver alone will produce rough-eye phenotypes (data not shown). Despite a 
lack of obvious morphological phenotypes, overexpression of TACE generally leads to 
lethality at pupal stage (unknown cause – summarized in Fig. A-6B-D). The absence of 
these phenotypes was validated in the few escapers that occurred and by dissecting un-
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hatched pupae to examine adult structures (e.g. bristles or eyes that are formed at pupal 
stage).   
 
Limited response of E(Spl) to changes in Delta, Kuz and Notch expression. The lack of 
E(Spl) response to TACE prompted us to examine if E(Spl) is responsive to other elements 
of the Notch pathway, namely Delta, Kuz and Notch itself. Whereas Kuz is required to 
activate E(Spl) in-vitro (Fig. A-5C), overexpression or knockdown of Kuz in the larval 
brain, wing disks or whole body did not lead to any detectable changes in E(Spl) 
expression (Fig. A-5D) but did lead to strong Notch-like phenotypes (Fig. A-2.I-O). There 
are several possible interpretations of these results. First, Kuz can produce Notch-like 
phenotypes through substrates other than Notch since it is known that similar phenotypes 
can be obtained by manipulating other signaling pathways. Second, Kuz can act through 
Notch but Notch itself might signal through targets other than E(Spl). Lastly, changes in 
E(Spl) expression that are necessary to affect phenotypes are below the detection limit of 
our qPCR system.  
E(Spl) showed limited response to the manipulation of Delta and Notch expression 
(Fig. A-5F). This response is much smaller than the one observed in-vitro where removal 
of Notch and Delta results in dramatic decrease of E(Spl) expression (Fig. A-5E).  
These results demonstrate that E(Spl) mRNA levels are only weakly linked to 
Notch signaling pathway and Notch phenotypes can be observed in the absence of 
detectable difference in E(Spl) expression.  
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Limited response of Mγ-lacZ reporter to modulation of Notch signaling. We also 
investigated the response of Mγ-lacZ reporter flies. In this construct, the expression of the 
lacZ gene is under the control of Mγ promoter that includes additional 12 repeats of Su(H) 
sites [8]. We crossed this strain to temperature-sensitive loss-of-function Notch mutants 
(NTS) and to hs-NICD flies that can disable or upregulate Notch signaling respectively in 
response to a heat-pulse.  The affect was analyzed by quantifying β-gal (protein product of 
lacZ gene) by immuno-florescence and by density analyses on Western blots (Fig. A-7). 
Consistent with the Notch RNAi results reported in the previous paragraph, we see 
detectable albeit small decrease in β-gal expression in the NTS>Mγ-lacZ cross (Fig. A-
7C,E) further corroborating that E(Spl) show only limited response to manipulation of 
Notch activity in-vivo.  
 
Mild response of E(Spl) expression to removal of Notch activity with NTS allele. We 
also tried to use temperature-sensitive loss-of-function Notch allele, NTS, to remove Notch 
activity by means other than RNAi.  The following protocol gave consistently strong Notch 
phenotypes and lethality: larvae were reared at 18°C until third instar followed by 
overnight at 30°C followed by 3 heat pulses at 37°C for 1 hour with 1 hour at 30°C in 
between heat pulses followed by overnight recovery at 30°C and then dissection in the 
morning. Response of individual E(Spl) genes varied depending on the tissue analyzed and 
was generally the strongest in the whole body (Fig. A-9). Overall, there was a general 
tendency for E(Spl) genes to decrease expression albeit no more than 50%, again arguing 
for a very weak link between Notch and E(Spl) in 3rd instar larvae. 
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Lack of Notch phenotypes in the optic lobes. While troubleshooting Notch expression, 
we consulted with Jason Boone from the laboratory  of Chris Doe (University of Oregon, 
Eugene) who informed us that they see Notch phenotypes in the larval optic lobe of NTS 
flies (temperature-sensitive loss-of-function Notch allele). We surmised this model may 
prove useful to analyze TACE effects on Notch signaling.  The Doe laboratory  reports a 
dramatic decrease in the overall size of the optic lobes and lack of the outer proliferative 
center (OPC) indicating lack of proliferation and differentiation (Jason Boone, personal 
communication).  We attempted to confirm these results using the classic NTS strain from 
the Bloomington stock center. We failed to validate both the size (Fig. A-8A-C) and the 
OPC phenotypes (Fig. A-8D,E). The Doe lab pointed that the NTS line from Bloomington is 
different from the NTS line used in the their laboratory .  These Notch phenotypes are only 
seen in the NTS flies that have 1st chromosome balancer and only for a few generations 
(although they have not validated that this strain actually has classic Notch phenotypes in 
the eye, bristles or wings). In addition, they failed to see these phenotypes with Notch 
RNAi or MARCM N55e (Notch null) and they generally have difficulty driving any RNAi 
constructs in the brain (Jason Boone, personal communication). 
 
A.3: Conclusions 
In-vivo results clearly demonstrate that TACE has no significant effect on E(Spl) 
expression in 3rd instar Drosophila larvae or on classic Notch phenotypes in the wing and 
bristles. Our previous in-vitro studies demonstrated that overexpressed TACE can very 
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potently activate Notch. However, overexpression of TACE in-vivo did not lead to any 
detectable increase in E(Spl) expression. These results suggest that Notch activation is 
tightly regulated and is context specific. It is likely that there are additional mechanisms 
that regulate ADAM activity toward Notch.   It should be noted that removal and addition 
of TACE expression in the giant-fiber circuit did lead to partial loss of jump response 
suggesting that TACE is involved in the development and/or physiology of this circuit. 
However, these results do not establish that TACE exerts its action via Notch or E(Spl) as 
opposed to another signaling pathway. 
Overall, manipulation of other components of the Notch pathway, namely Kuz, 
Delta and Notch revealed a weak link between Notch activation and E(Spl) expression in 
larval tissues suggesting that Notch itself acts through targets other than E(Spl). The 
identity of additional Notch targets is currently unknown.  These results contradict current 
understanding that E(Spl) genes are immediate targets of Notch in all contexts. In fact, the 
evidence for this hypothesis is strong for embryos [9] but rather weak in the larval tissues. 
Published data fails to convince that removal of Notch in wing discs leads to a dramatic 
drop in E(Spl) expression [10]. In fact, removal of the entire E(Spl) locus in the wing disk 
leads to only mild Notch wing phenotype [11] again arguing that there are other targets of 
activated Notch. The identity of these targets is unknown but it would be a relatively easy 
experiment to determine them by comparing mRNA expression with micro-arrays in wild-
type and NTS flies where Notch signaling is removed at larval stage. 
Of technical significance, we found that it can be difficult to confirm the 
effectiveness of RNAi by quantitative RT-PCR. We see examples where induction of 
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RNAi expression does not produce detectable knockdown of target mRNA expression but 
does produce adult phenotypes associated with loss of function in this gene. To be more 
convincing, it is advisable to increase the strength of RNAi induction by either duplicating 
the copy number of the driver, the UAS-RNAi construct or by adding additional Dicer2 




[1] Duffy, J.B. (2002). GAL4 system in Drosophila: a fly geneticist's Swiss army 
knife. Genesis 34, 1-15. 
[2] Yang, M., Nelson, D., Funakoshi, Y. and Padgett, R.W. (2004). Genome-wide 
microarray analysis of TGFbeta signaling in the Drosophila brain. BMC Dev Biol 
4, 14. 
[3] Cha, G.H., Kim, S., Park, J., Lee, E., Kim, M., Lee, S.B., Kim, J.M., Chung, J. 
and Cho, K.S. (2005). Parkin negatively regulates JNK pathway in the 
dopaminergic neurons of Drosophila. Proc Natl Acad Sci U S A 102, 10345-50. 
[4] Cooper, M.T., Tyler, D.M., Furriols, M., Chalkiadaki, A., Delidakis, C. and Bray, 
S. (2000). Spatially Restricted Factors Cooperate with Notch in the Regulation of 
Enhancer of split Genes. Dev Biol 221, 390-403. 
[5] Huppert, S.S., Jacobsen, T.L. and Muskavitch, M.A. (1997). Feedback regulation 
is central to Delta-Notch signalling required for Drosophila wing vein 
morphogenesis. Development 124, 3283-91. 
[6] Sotillos, S., Roch, F. and Campuzano, S. (1997). The metalloprotease-disintegrin 
Kuzbanian participates in Notch activation during growth and patterning of 
Drosophila imaginal discs. Development 124, 4769-79. 
[7] Presente, A., Shaw, S., Nye, J.S. and Andres, A.J. (2002). Transgene-mediated 
RNA interference defines a novel role for notch in chemosensory startle behavior. 
Genesis 34, 165-9. 
 164
[8] Go, M.J., Eastman, D.S. and Artavanis-Tsakonas, S. (1998). Cell proliferation 
control by Notch signaling in Drosophila development. Development 125, 2031-
40. 
[9] Jennings, B., Preiss, A., Delidakis, C. and Bray, S. (1994). The Notch signalling 
pathway is required for Enhancer of split bHLH protein expression during 
neurogenesis in the Drosophila embryo. Development 120, 3537-48. 
[10] Jennings, V., de Celis, J., Delidakis, C., Preiss, A. and Bray, S. (1995). Role of 
Notch and achaete-scute complex in the expression of Enhancer of split bHLH 
proteins. Development 121, 3745-3752. 
[11] de Celis, J.F., de Celis, J., Ligoxygakis, P., Preiss, A., Delidakis, C. and Bray, S. 
(1996). Functional relationships between Notch, Su(H) and the bHLH genes of 
the E(spl) complex: the E(spl) genes mediate only a subset of Notch activities 























 M3       Mβ       Mγ
11





Brain 4.7 16.5 1.7 1.5 1.3 8.8 2.1 5.0 17.4 13.5
Whole larvae 1.7 1.1 2.0 2.1 0.07 1.3 1.4 4.9 4.5 5.9
Wing disk 3.9 0.2 1.6 0.7 0.02 15.6 4.5 18.9 2.3 11.4


















Figure A-1. Profile of gene expression of select components of the Notch signaling pathway and 
ADAMs. 
 
(A) Profile of gene expression of select components of the Notch signaling pathway and ADAMs in 3rd 
instar (L3) Drosophila brain, wing disk and whole body. Values indicate quantitative RT-PCR results 
representing mRNA levels in arbitrary units (a.u.) obtained by multiplying RQ by 1000 where RQ=2^(-
∆Ct) and ∆Ct=Ct (target gene) – Ct (RP49). RP49, the housekeeping gene. Of note is the elevated 
expression of TACE in the larval brain, elevated Notch expression in the larval brain and wing disk, flat 
expression of Kuz, high enrichment of the ADAM Mind-meld (Mmd) in the brain. (B) TACE-induced 
Notch activation in C6 cells results in dramatic increase of E(Spl) gene expression. Fold change of M3, Mβ 
and Mγ expression following TACE-specific activation of Notch in C6 cells. 
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Figure A-2. Characterization of UAS fly strains used in the study. 
 
Characterization of UAS-TACEHA construct in-vitro and in-vivo. (A) Expression of TACEHA in the 
whole body with the hs-gal4 driver leads to increase in Notch cleavage as seen by the increase in NCTF 
product thereby showing that TACEHA has catalytic activity. Expression of TACEHA  at 18°C is minimal. 
Induction of hs-gal4 driver at 37°C leads to effective increase in TACEHA expression. NFL; full length 
Notch; NCTF, C-terminal fragment of Notch. β-tubulin is used as a loading control. (B) TACE expression 
can be induced in several larval tissues using tissue-specific gal4 drivers. Levels of TACEHA 
overexpression relative to the levels of endogenous TACE, as measured by quantitative RT-PCR of 
mRNA, in brain (elav-gal4 driver), wing disk (A9-gal4 driver) and whole body (hs-gal4 driver). (C) As 
shown in the chapter 4, TACE is effective at cleaving Notch. Overexpression of TACE in C6 cell line leads 
to dramatic increase in Notch cleavage as seen by accumulation of NCTF product. (D) Expression of 
TACEHA  in the eye with the GMR-gal4 driver leads to glossy eye phenotype. 
 
 167
Effect of UAS-TACE RNAi induction with 























Figure A-2 (continued). Characterization of UAS fly strains used in the study. 
 
Characterization of UAS-TACE RNAi construct in-vitro and in-vivo. (E) UAS-TACE RNAi is 
effective in reducing protein expression of TACE. Drosophila S2 cells were co-transfected with TACEHA 
and UAS-TACE RNAi constructs, and cell lysates were run on SDS-PAGE and Western blotted with anti-
HA antibody. (F) Ten transgenic fly lines expressing UAS-TACE RNAi construct were made through the 
service of BestGene, Inc. Lines #2,3,4,5,6 were tested for the effectiveness on reducing TACE mRNA 
levels using hs-gal4 drives and analyzing TACE gene expression in the whole 3rd instar larvae using q-RT-
PCR. Hs>w1118, control cross. (G,H) Expression of TACE RNAi in the bristles and wings with A9-gal4 











Figure A-2 (continued). Characterization of UAS fly strains used in the study. 
 
Characterization of UAS-Kuz RNAi construct in-vivo. Induction of Kuz RNAi is very effective at 
eliciting Notch phenotypes of bristle duplications / deletions and thick wing veins. (I-K) Expression of Kuz 
RNAi in the wing (I) and bristles (J,K) with A9-gal4 driver leads to vein thickening and bristle 



























Figure A-2 (continued). Characterization of UAS fly strains used in the study. 
 
Characterization of UAS-Kuz construct in-vivo. (M) Kuz can be overexpressed in wings disks (using 
A9-gal4 driver) and whole larvae (using hs-gal4 driver). Overexpression of Kuz in brain with elav-gal4 
driver is lethal at embryonic stage. q-RR-PCR results showing fold change in Kuz mRNA levels following 
the induction of UAS-Kuz expression. (N,O) Induction of UAS-Kuz in the bristles and wings with A9-gal4 














































Figure A-2 (continued). Characterization of UAS fly strains used in the study. 
 
Characterization of UAS-Notch RNAi and NotchICD constructs in-vivo. (P-S) Induction of Notch RNAi  
in the eye with GMR-gal4 driver (P) and bristles / wings with A9-gal4 driver (Q-S) leads to strong Notch 
phenotypes (glossy/melted eyes, bristle duplications / deletions and thick wing veins). (T-U) Notch 
signaling can be upregulated by overexpressing intracellular domain of Notch. (T) UAS-NotchICD can be 
induced in various tissues using tissue-specific drivers. Induction of UAS-NotchICD expression is be 
measured by q-RT-PCR. (U) Expression of UAS-NotchICD in the eye with GMR-gal4 driver (GMR>NICD) 




































Figure A-2 (continued). Characterization of UAS fly strains used in the study. 
 
Characterization of UAS-Delta RNAi and UAS-Delta constructs in-vivo. (V-X) Reduction of Delta 
expression in bristles and wings with A9-gal4 driver leads to strong Notch phenotypes of missing / 
duplicated bristles and thick wing veins.  (Y-Z) UAS-Delta can be induced in various tissues using tissue-
specific drivers. Induction of UAS-Delta expression is be measured by q-RT-PCR. (Z) Expression of UAS-
Delta in the eye with GMR-gal4 driver leads to glossy eye phenotype and strong morphological 
















































































































Figure A-3. Heat-shock driver fails to induce expression in the brain. Failure to detect the effect of 
RNAi on mRNA levels. 
 
(A-B) hs-gal4 driver fails to drive in the larval brain. (A) Levels of Gal4 expression do not increase in the 
brain following a heat-pulse while they do in the whole larvae. (B) hs-gal4 fails to induce expression of 
UAS-TACE in the larval brain while it is effective at inducing TACE expression in the whole larvae. (C) 
Elav-gal4 driver is much more effective in driving Gal4 expression in the brain than hs-gal4. q-RT-PCR 
results showing relative expression of gal4 in the larval brain in hs-gal4 (following a heat-pulse) and elav-
gal4 flies. (D) The effect of RNAi on knockdown of expression can not be detected by quantitative RT-
PCR method. Graph shows change in mRNA expression of TACE, Notch, Kuz and Delta in the larval brain 
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Figure A-4. Expression in larval brain and wing disks.  
(A-B) Schematic of larval brain and location of proliferative neuronal precursors. (C-F) Confocal images 
showing co-localization of Notch, Delta and Mβ expression using immunostaining. Confocal planes are 
outlined in (C). (G) Expression domain of A9-gal4 driver (A9>CD8-GFP cross). (H-K) Whole-mount 
images of the expression of Mβ (H, modified from [4]), Kuz (I, modified from [6]), Notch and Delta (J,K, 
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Figure A-5. Effects of TACE, Kuz, Notch and Delta on E(Spl) expression. 
(A) TACE strongly activates Notch in C6 cells as measured by the expression of Mβ gene (see chapter 4). 
(B) TACE does not affect Notch activation in-vivo as measured by the expression of Mβ gene. UAS-TACE 
RNAi (TACE-) and UAS-TACE (TACE+) constructs were expressed in the brain (elav-gal4 driver), wing 
disks (A9-gal4 driver) and whole larvae (hs-gal4 driver) and the effect of these constructs on Mβ 
expression was measured by q-RT-PCR. (C) Kuz is very potent Notch activator in C6 cells (see chapter 4). 
(D) Kuz does not affect Notch activation in-vivo as measured by the expression of Mβ gene. UAS-Kuz 
RNAi (Kuz-) and UAS-Kuz (Kuz+) constructs were expressed and analyzed the same way as in (B) (E) 
Mβ expression in C6 cells is Notch and Delta dependent (see chapter 4). (F) Notch and Delta only weakly 
regulate E(Spl) in-vivo. UAS-Notch RNAi (N-), UAS-NotchICD (N+), UAS-Delta RNAi (Dl-) and UAS-
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UAS-Nintra lethal lethal at pre-pupal stage not tested not tested
;UAS-Dli lethal
viable: thick veins, vein 
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;UAS-Dl viable: wing; "melted" eye lethal at pupal stage not tested not tested
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phenotype viable: no phenotype viable: no phenotype viable: no phenotype  
Figure A-6. Summary of jump response and other Notch phenotypes.  
(A) Jump response phenotype in wild-type (A307>CD8-GFP) flies and flies whose TACE, Notch, Delta, 
and Kuz expression levels were manipulated down (A307>TACEi#2, A307>Ni, A307>Dli and A307>Ki) 
or up (A307>Dl and A307>TACE-HA). (B-D) Summary of adult phenotypes observed with various drivers  
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summary of phenotypes 
Cross: 9-19-2007, raised at 18C
GMR-gal4
UAS-Ni lethal at  pupal stage; late pupae have severely "melted" eyes with complete loss of red pigment 
UAS-Nintra lethal at  pupal stage; late pupae have strongly "melted" eyes with loss of red pigment 
;UAS-Dli viable; strong "melted" eyes
;UAS-Dl viable; strong "melted" eyes
;;UAS-Kuz viable; strong "melted" eyes
;UAS-Ki viable; mostly normal eyes with some flies having spots of "melted" eyes
;UAS-TACE
lethal at  pupal / early post-pupal stage; late pupae / 
early eclosers have strongly "melted" eyes similar to 
Dl, Dli and KUZ  
;UAS-CD8-GFP viable: no phenotype
summary of phenotypes (females)
Cross: 8-22-2007, raised at 29C
w11118 GMR-gal4 A9-gal4;Sco/Cyo A307-gal4
UAS-Ni viable lethal lethal lethal
UAS-Nintra viable lethal lethal lethal
;UAS-Dli viable lethal viable: wing; extra/missing bristles lethal
;UAS-Dl viable lethal lethal lethal
;;UAS-Kuz viable lethal lethal lethal
;UAS-Ki viable viable viable: thick L3/L5 veins, bristle dupl (head)  viable
;UAS-TACE/cyo viable lethal lethal lethal





Figure A-6 (continued). Summary of jump response and other Notch phenotypes. 
 






































Figure A-7. Limited response of Mγ-lacZ reporter to inactivation of Notch in larval brain and whole 
larvae  
 
(A-C) Expression of Mγ12X-lacZ reporter was analyzed in NTS flies with and without inactivating heat-
pulse. (A,B) Confocal images of ventral surface of the larval thoracic ganglion show immunostaining for β-
gal (protein product of lacZ gene) with quantification in (C). (D,E) β-gal protein expression from whole 




















Canton L3 brains NTS L3 brains
Canton OPC NTS OPC  
Figure A-8. Lack of Notch phenotypes in the optic lobes.  
Loss of Notch signaling is the optic lobes is supposed to lead to two detectable phenotypes: smaller size 
and loss of outer proliferative center (OPC). Loss of Notch signaling in NTS flies does not lead to a 
detectable change in the size of optic lobes (A,B and quantified in C) or in proliferation and differentiation 
in OPC (D,E). (D) Wild-type late L3 optic lobes stained with antibody against Dlg (adherence junction 
marker – stains cell surface of cells) showing OPC transitioning to neuroblasts. (E) NTS late L3 optic lobes 
stained with Dlg showing no effect of removing Notch signaling on OPC transitioning to neuroblasts. 
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Figure A-9. Weak response of E(Spl) to removal of Notch with NTS.  
 
Graph shows the effect of removal of Notch signaling with NTS allele on the expression levels of several 











































Figure A-10. Effect of Notch RNAi on the levels of Notch mRNA, protein and phenotypes.  
 
(A-D) Results of one experiment where Notch RNAi was driven with hs-gal4 driver using strong induction 
protocol (see text for details) that led to Notch phenotypes (D), noticeable knockdown in Notch protein 
expression (A) quantified in (B) and Notch mRNA expression (C) and Notch target genes (C). However, 
the magnitude of decrease in E(Spl) genes is essentially within the error margin of quantitative PCR 




APPENDIX B:  
RECK DOES NOT REGULATE KUZ ACTIVITY IN DROSOPHILA 
 
B.1: Background 
Kuz and other ADAMs are potent proteases of the Delta ligand. However, little is 
known about how the activity of these ADAMs is regulated. The Takahashi group in 
Japan has shown recently that in mammals, RECK (reversion-inducing-cysteine-rich 
protein with Kazal motifs) has strong inhibitory activity against ADAM10 (Kuz 
homolog) and this inhibitory activity is required for Delta to be in the un-cleaved form 
and be able to signal to Notch [1].  In the absence of RECK, Delta is cleaved by 
ADAM10 and there is no Notch activation as determined by severe Notch phenotype and 
lack of HES expression (immediate targets of Notch activation in mammals) [1].  We 
therefore decided to see if the role of RECK is conserved in Drosophila. 
 
B.2: Results 
Characterization of Drosophila RECK: Mouse RECK is a 971 amino acid  GPI-
anchored serine protease inhibitor (Fig. B-1A) that shows strong inhibitory activity 
against MMPs and ADAM10 [1-3]. It has three KAZAL domains (C-X7-C-X6-Y-X3-C-
X2,3-C)) that are essential for inhibiting serine proteases [2].  Drosophila RECK is a 1071 
amino acid protein that has not yet been characterized. Computational analysis shows that 
its sequence meets the criteria for being a GPI-anchored protein and that it has three 
conserved KAZAL motifs (Fig. B-1B). 
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Profile of RECK expression: Gene expression analysis revealed that RECK is 
highly expressed in all Drosophila larval tissues and cell lines analyzed except for C6 
cells, which show very little RECK expression (Fig. B-2). 
 
RECK is not required for Kuz-dependent cleavage of Delta: We asked if RECK 
modulates Kuz activity towards Delta. Since DlS2 cells express high level of RECK, we 
assayed Kuz-dependent cleavage of Delta in DlS2 cells that were treated with RNAi 
against RECK. RNAi treatment is effective in reducing RECK expression at the mRNA 
level (Fig. B-3B) but has no effect on the cleavage of Delta, as seen by an un-altered 
profile of cleavage products in DlS2 cells (Fig. B-3A). From these preliminary 




Our data suggests that RECK activity in Drosophila is not conserved with respect 
to Kuz cleavage of Delta. In addition, our preliminary results show no effect of RECK on 
Notch cleavage and Kuz-dependent Notch activation (data not shown).  Further studies 
are needed to exclude a role for RECK in Notch signals in Drosophila, preferably using 
cells that express higher levels of RECK. Additional data points can be obtained by 
cloning RECK into an expression vector and looking at the effect of RECK 
overexpression on Delta cleavage and Notch activation in-vitro. Additionally, in-vivo role 
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of RECK can be analyzed by obtaining UAS-RECK RNAi fly line (available through the 
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Figure B-1. Structure and sequence of RECK. 
 (A) Structure of mouse RECK (modified from [2]). (B) Comparison of mouse and Drosophila RECK 
sequences using Clustal W (version 1.83) sequence alignment algorithm. KAZAL and GPI-anchored motifs 
are underlined. 
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Figure B-2. Profile of RECK expression. 
 
Profile of RECK expression in Drosophila larval tissues and cell lines as determined by quantitative RT-
PCR (q-RT-PCR). Y-axis represents gene expression in arbitrary units (a.u.) obtained by using the 


























Figure B-3. Effect of RECK on Kuz-dependent cleavage of Delta. 
 
(A) Knockdown of RECK expression does not lead to change of Delta cleavage as determined by 
unchanged levels of P1 and P2 products on the Westerns. DlS2 cells that were treated with RECK RNAi 
and cell lysates and media were Western blotted with 10D5 and 9B antibodies respectively. Equal loading 
was ensured by BCA assay and checked by staining with anti β-tubulin antibody. DlFL, full-length Delta. 
P1 and P2, cytosolic products of Delta cleavage. DlECD, extracellular domain of Delta. (B) The effect of 
RECK RNAi on the RECK mRNA expression as measured by q-RT-PCR. 
